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ABSTRACT
Neural Stem Cells (NSCs) are self-renewing multipotent populations 
responsible for the generation of neurons and glial cells of the developing brain and 
account for the limited regenerative plasticity of the adult brain. In view of their 
reliable use as cellular model to study neurodegenerative diseases, and as 
potential donors in cell-based therapeutic approaches, we have isolated and 
characterized NSCs from a mouse model of a neurodegenerative Lysosomal 
Storage Disorder (LSD), the Multiple Sulfatase Deficiency (MSD), caused by 
mutations in the sulfatase modifying factor 1 (SUMF1) gene that encodes the 
enzyme responsible for sulfatase activation.
Isolated MSD-NSCs are phenotypically similar to wild-type precursors and are 
able to differentiate into neurons and astrocytes, although they show a progressive 
loss of their self-renewal capacity. Moreover, differentiated MSD cells recapitulate 
the main pathological features of the disease, such as progressive cell 
vacuolization, lysosomal accumulation of glycosaminoglycans (GAGs), altered 
autophagy with accumulation of poly-ubiquitinated proteins, and increased levels of 
apoptosis. Interestingly, glia-differentiated MSD cells display the tendency to form 
aggresomes, perinuclear aggregates of misfolded protein, which is a common 
feature to many neurodegenerative diseases.
We also showed that the overexpression of the Transcription Factor EB 
(TFEB), a master-gene that modulate lysosomal function and autophagy, induces 
lysosomal exocytosis through activation of mucolipin 1 (MCOLN1) and reduces
significantly primary and secondary pathologic storage, ameliorating the phenotype 
of MSD cells (Medina et al. 2011).
These results validate the use of NSCs isolated from LSD mouse models to 
study their neurodegenerative phenotype, and envisage their use to explore new 
therapeutic approaches by the modulation of TFEB expression in LSDs.
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INTRODUCTION
The lysosome
Lysosomes are cellular organelles present in all cell types, which are primarily 
involved in degradation and recycling processes (Kornfeld and Mellman 1989). The 
lysosome was first described by de Duve in 1955 as an acidic organelle containing 
a set of lysosomal enzymes (De Duve et al. 1955), whose function is the 
degradation of other cellular components. The first morphological demonstration of 
lysosomes by electron microscopy of organelles prepared from rat liver was 
presented by Alex Novikoff in 1956 (Novikoff, Beaufay, and De Duve 1956). Since 
these early days, much has been learned about lysosomes and related organelles, 
about their diverse functions, biogenesis and failures in disease.
According to its physiological function at different stages, lysosome can be 
divided into the primary lysosome, the secondary lysosome and the residual body 
(Zhang et al 2009). Primary lysosomes are membrane-bound intracellular 
organelles that contain a variety of hydrolytic enzymes; they fuse with membrane- 
bound vacuoles that contain material to be digested, forming secondary 
lysosomes. Once in the lumen of lysosomes, substrates are then degraded via a 
finely orchestrated network of soluble lysosomal hydrolases (also referred to as 
acid hydrolases), integral lysosomal membrane proteins (LMPs), lysosomal related 
organelles (LROs) and other cellular constituents (Saftig and Klumperman 2009).
After digestion occurred, secondary lysosomes become residual bodies, containing 
only indigestible or slowly digestible materials and within which enzymatic activities 
have become virtually exhausted (Zhang et al 2009).
Macromolecules are delivered toward lysosomes for degradation from the 
extracellular space through endocytosis or phagocytosis, as well as from the 
cytoplasm through autophagy (Doherty and McMahon 2009; Kornfeld 1986; 
Ravikumar et al. 2009). Due to their crucial function, lysosomes are involved in 
various cellular processes, such as cholesterol homeostasis (Lange at al. 1998), 
membrane repair (Reddy et al. 2001), bone and tissue remodelling (Chapman et al. 
1994), pathogen defence (Kanai et al. 1970), signal transduction (Mandeville et al.
1996), cell division (Allison and Mallucci 1964), neurotransmission (Holtzman 
1977) and cell death (Guicciardi et al. 2004). These complex functions highlight the 
fact that the lysosome is a central organelle which is much more than just the 
wastebasket of the cell (Saftig 2006).
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Components of lysosomes
As De Duve initially observed, lysosomes are limited by a single phospholipid 
bilayer. Their shape varies between globular and tubular (Saftig and Klumperman 
2009) and their detailed structure differs depending on the cell type. In fact, 
lysosomes can be morphologically heterogeneous due to differences in their 
internalized content. This heterogeneity of the lysosomal content appears usually 
electron-dense but often includes irregularities and membrane sheets (Saftig and 
Klumperman 2009).
A common characteristic of lysosomal compartments is their acidic interior 
with a pH of 4.5-5, which is maintained by the vacuolar H+-adenosine 
triphosphatases (v-ATPase), a transmembrane multiprotein complex (Schroder et 
al. 2010). Preservation of low pH is important for several lysosomal functions, such 
as cargo release, hydrolase maturation, vesicle maturation, autophagy and 
neurotransmitter loading into synaptic vesicles (Marshansky and Futai 2008; 
Mijaljica, Prescott, and Devenish 2011). Additionally, the pH gradient within the 
endomembrane system is required for intracellular trafficking and its loss can 
impair mannose-6-phosphate receptor (M6PR) recycling back to the Golgi for 
reloading of newly synthesized lysosomal hydrolases (Sobota et al. 2009).
Lysosomes contain more than 50 different acid hydrolases, such as 
proteinases, peptidases, phosphatases, nucleases, glycosidases, sulfatases and 
lipases, and several activator proteins that are localised mainly in the matrix. These 
hydrolases are then able to decompose macromolecules and even membranes 
into their monomeric constituents.
In other studies, it has been shown that cells can also contain lysosome-like 
organelles, such as melanosomes, lytic granules, major histocompatibility complex 
(MHC) class II compartments, platelet-dense granules and synaptic-like micro­
vesicles (Dell’Angelica 2004). Nevertheless, acid hydrolases and LMPs are 
essential for the function of lysosomes.
Acid hydrolases
Each of the 50 known lysosomal acid hydrolases targets specific substrates 
for degradation, and their collective action is responsible for the total catabolic 
capacity of the lysosome (Saftig and Klumperman 2009). The breakdown products, 
such as amino acids, monosaccharides, oligosaccharides and nucleotides, are 
then transported back to the cytosol by specific transporter proteins residing in the 
lysosomal membrane (Saftig 2006). In addition to bulk degradation and pre-protein 
processing, lysosomal hydrolases are also involved in antigen processing, 
degradation of the extracellular matrix and initiation of apoptosis (Conus and Simon 
2008).
Lysosomal targeting of newly synthesized lysosomal proteins can be (1) 
direct, from the trans-Go\g\ network (TGN) to the endosomal system, or (2) indirect, 
involving transport to the plasma membrane and subsequent endocytosis (Saftig 
and Klumperman 2009).
Most newly synthesized lysosomal hydrolases enter the lysosomal 
compartment directly via the biosynthetic route (Figure 1). They are synthesized in 
the rough endoplasmic reticulum (ER) and then packaged into vescicles in the
Golgi apparatus. In the TGN, acid hydrolases undergo a critical modification of one 
or several of their carbohydrates to mannose-6-phosphate (M6P) moieties by the 
enzyme N-acetylglucosamine (GlcNAc)-phosphotransferase (Hasilik, Waheed, and 
von Figura 1981; Sleat et al. 2005); then acid hydrolases bind the M6PR that 
delivers them to endosomes (Kornfeld and Mellman 1989). There are two types of 
M6PR, 300 kD cation-independent M6PR (CIM6PR; also known as IGF2R) and 46 
kD cation-dependent M6PR (CDM6PR), both of which are ubiquitously expressed 
(Braulke and Bonifacino 2009). As the v-ATPase leads to acidification during the 
maturation of the endosomal compartment, the hydrolases dissociate from their 
receptors, which are then recycled back to the trans-Golgi network or to the cell 
surface (Saftig 2006) (Figure 1).
In the absence of a functional M6PR pathway, newly synthesized lysosomal 
hydrolases do not acquire M6P tags because of a deficiency in N- 
acetylglucosamine (GlcNAc)-phosphotransferase activity, also known as l-cell 
disease or mucolipidosis type II (Hasilik, Waheed, and von Figura 1981; Waheed et 
al. 1982; Reitman, Varki, and Kornfeld 1981). Nevertheless, in some l-cell diseased 
cells, a significant portion of newly synthesized lysosomal hydrolases do reach the 
lysosome (Waheed et al. 1982; Little et al. 1987; Owada and Neufeld 1982). In this 
condition, new hydrolases can follow the constitutive secretory pathway to the 
plasma membrane and after secretion might be taken up by endocytosis.
10
Lysosomal Membrane Proteins
Lysosomes are surrounded by a single phospholipid bilayer that serves as a 
limiting membrane. Such lysosomal membrane has several functions including 
sequestration of lysosomal enzymes, mediation of fusion events, acidification of the 
lysosomal lumen and transport of degradation products to the cytoplasm (Saftig 
2006). In fact, the lysosomal membrane gathers the aggressive hydrolases to the 
organelle lumen, thus preventing undesired proteolytic damage to the 
surroundings; at the same time, it forms an impermeable barrier for the monomeric 
metabolites originating from the degradation of macromolecules, preventing their 
leakage in the cytoplasm. Therefore selective transport proteins are required in 
order to clear these compounds from the lysosomal lumen and facilitate their efflux 
into the cytosol.
LMPs are highly glycosylated proteins decorating the luminal surface of 
lysosomal membranes (Koike et al. 2005). The mammalian lysosome contains -25 
LMPs (Lubke, Lobel, and Sleat 2009), although additional LMPs are currently being 
revealed (Lubke, Lobel, and Sleat 2009; Schroder et al. 2007; Callahan, Bagshaw, 
and Mahuran 2009). The most abundant LMPs are lysosome associated 
membrane protein 1 and 2 (LAMP1 and LAMP2), lysosome integral membrane 
protein 2 (LIMP2, also known as SCARB2) and the tetraspanin CD63 (Saftig and 
Klumperman 2009). The sorting of most lysosomal membrane proteins depends on 
short sequence motifs within their cytoplasmic tails, which are necessary and 
sufficient to target them to lysosomes (Saftig 2006).
Furthermore, lysosomal membranes are characterized by a system of
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transporters that play several important roles, such as establishing controlled acidic 
pH in the lysosome, absorption of the products of digestion, the release of Ca2+ 
from the lysosomal lumen that drives the fusion of lysosomes with late endosomes, 
and transport of the metals bound to endocytosed proteins across the lysosomal 
membrane into the cytoplasm (Ruivo et al. 2009; Jentsch 2007; Luzio et al. 2005). 
Among them, lysosomes contain also members of the transient receptor potential 
(TRP) superfamily; in particular, a key role is played by MCOLN1, an ion channel 
belonging to the subfamily of mucolipins (TRPMLs), which localizes also to late 
endosomes membrane. It has been shown that the channel is permeable to 
multiple ions including Ca2+, Fe2+, Na+, K+, Zn2+ and H+ (X.-P. Dong et al. 2008; 
LaPlante et al. 2002; Raychowdhury et al. 2004) and therefore it appears to be a 
prominent lysosomal metal transporter. Although the exact function of MCOLN1 
remains to be conclusively proven, it is becoming evident that it functions as a 
lysosomal Ca2+ release channel. Membrane trafficking deficits (Treusch et al. 
2004), as well as impaired fusion of lysosomes with autophagosomes in MCOLN1 
deficient cells (Vergarajauregui and Puertollano 2006) support the role of 
MCOLN1-mediated Ca2+ release in the Ca2+-dependent membrane fusion along 
the endocytic pathway.
Besides transport proteins, the membrane also contains other enzymes, 
including the heparan-a-glucosaminide N-acetyltransferase (HGSNAT), which uses 
cytosolic acetyl coenzyme A for the acetylation of non-reducing terminal a- 
glucosaminyl residues of the heparan sulphate degradation intermediates in the 
lysosomal matrix (Fan et al. 2006; Hrebfcek et al. 2006).
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Figure 1. Transport of newly synthesized lysosomal hydrolases to 
lysosomes.
Lysosomal hydrolases are synthesized in the endoplasmic reticulum and move to 
the cis-Golgi network (CGN), were they are covalently modified by the addition of 
M6P groups. At the TGN, the M6P signal allows the segregation of lysosomal 
hydrolases from all other types of proteins through selective binding to the M6P 
receptors. The clathrin-coated vesicles produced bud off from TGN and fuse with 
late endosomes. At the low pH of the late endosome, the hydrolases dissociate 
from the M6PRs and the empty receptors are recycled to the Golgi apparatus for 
further rounds of transport.
Model taken from Coutinho et al. 2012
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Lysosomal Related Organelles
LROs are specialised lysosomes with cell-type specific functions, such as 
melanosomes in melanocytes, Weibel-Palade bodies in endothelial cells, lamellar 
bodies in type II pneumocytes, dense bodies in plateles and granules in cytotoxic T 
cells and natural killer cells (Raposo, Marks, and Cutler 2007). LROs usually co­
exist with normal lysosomes. They share features of late endosomes/lysosomes 
but are functionally, morphologically and compositionally distinct; they can also 
contain cell-type-specific proteins and might require additional cellular machinery 
for their biogenesis (Bonifacino 2004; Dell’Angelica 2004). Some LROs resemble 
lysosomes morphologically with electron-dense protein deposits and/or 
intralumenal membranes, and are accessible to endocytic traffic (Raposo, Marks, 
and Cutler 2007); other LROs present entirely novel morphological features as a 
product of their unique cargo, such as the proteinacious fibrils of melanosomes, the 
proteinacious tubules of Weibel-Palade bodies and the lipid swirls within lamellar 
bodies (Raposo and Marks 2002; Bonifacino 2004).
Together with lysosomes, LROs are involved in various physiological 
processes, such as cholesterol homeostasis, plasma membrane repair, bone and 
tissue remodelling, pathogen defence, cell death and cell signalling (Saftig and 
Klumperman 2009).
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Function of lysosomes
Lysosomes are involved in several cellular processes including endocytosis, 
phagocytosis, autophagy and exocytosis (Figure 2).
Endocytosis and Lysosome Formation
One of the most important functions of lysosomes is the digestion of material 
taken up from outside the cell through endocytosis. However, this function is 
directly related also to lysosome formation within the cell. In other words, lysosome 
biogenesis represents an intersection between the secretory pathway, through 
which lysosomal proteins are processed, and the endocytic pathway, through 
which extracellular molecules are taken up at the cell surface. Specifically, 
lysosomes are formed by the fusion of transport vesicles budded from the TGN 
with endosomes, but they can also contain molecules taken up by endocytosis and 
coming from the plasma membrane. Material from outside the cell is taken up in 
clathrin-coated endocytic vesicles, which bud from the plasma membrane and then 
fuse with early endosomes. Membrane components are then recycled to the 
plasma membrane and the early endosomes gradually mature into late 
endosomes, which are the precursors to lysosomes. In addition, early endosomes 
receive also endogenous proteins from the TGN, such as M6PRs carrying acid 
hydrolases (Klumperman et al. 1993; Waguri et al. 2003) to be delivered to the 
lysosome; in this step, one of the important changes during endosome maturation 
is the lowering of the internal pH to about 5.5 (Figure 1).
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Acid hydrolases are then targeted to lysosomes by mannose-6-phosphate 
residues, which are recognized by M6PRs in the TGN and packed into clathrin- 
coated vesicles (Rohrer and Kornfeld 2001). The clathrin coat is then removed and 
transport vesicles fuse with late endosomes, causing the acidification of the internal 
pH; this change in the internal pH causes the dissociation of hydrolases from the 
M6PR. The hydrolases are thus released into the lumen of the endosome, while 
M6PRs remain in the membrane and are eventually recycled to the Golgi (Figure 
2). As late endosomes acquire a full complement of acid hydrolases they mature 
into lysosomes.
16
Figure 2. Lysosomes are involved in several cellular processes and undergo 
maturation.
Lysosomes participate in endocytosis, phagocytosis, autophagy and exocytosis. 
During their biogenesis and maturation they are subjected to a few steps of 
maturation. Primary lysosomes contain hydrolytic enzymes, they fuse with other 
endocytic vesicles that contain material to be digested, forming secondary 
lysosomes; once digestion occurred, secondary lysosomes become residual 
bodies, containing only indigestible or slowly digestible materials.
Modified from The McGraw-Hill Companies, Inc. 2006
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Autophagy
The lysosome is the end-terminal for substrates coming from the autophagy 
pathway. Autophagy is a mechanism by which the cell digests its own intracellular 
components and other organelles, such as mitochondria (Figure 1 and 3). This 
process secures the cell’s supply with macromolecules under conditions of 
starvation and allows the disposal of unneeded and non-functional organelles 
(Schroder et al. 2010).
Autophagy also was first observed by de Duve in 1963 (De Duve 1963); he 
identified membrane-bound vesicles containing endogenous organelles undergoing 
digestion; various stimuli, including starvation and glucagon administration, 
stimulate this process.
Autophagy is critical for growth, development and survival and therefore it is 
highly conserved among eukaryotic organisms, from yeasts to mammals (T Lang et 
al. 2000; Noda et al. 2000; Young et al. 2006).
There are various types of autophagy, differing in their mechanisms and 
functions (Klionsky 2005): microautophagy, macroautophagy and chaperone- 
mediated autophagy (CMA). Microautophagy is the non-selective internalization of 
small cytosolic portions via lysosomal invaginations. Macroautophagy (hereafter 
referred to as autophagy) is the selective sequestration of cytoplasm or organelles 
that are enclosed in the double-membrane structures known as autophagosomes, 
which subsequently fuses with lysosomes. CMA is the selective targeting of 
specific cytosolic soluble proteins to the lysosome via molecular chaperones. This 
latter process involves a direct translocation of the unfolded protein through the
18
lysosomal membrane by a mechanism not fully clarified, although critically 
depending on an isoform of the lysosome-associated membrane protein 2 
(LAMP2A) as an essential component.
The first step of autophagy appears to be the formation of a cup-shaped 
structure, also referred to as an isolation membrane or pre-autophagosome, in the 
cytosol, where it gradually elongates to surround a portion of the cytoplasm and its 
constituents (Figure 3). Subsequently, the edges of the membrane fuse together to 
form a vesicle, which represents a double-membrane structure termed 
autophagosome (Juhasz and Neufeld 2006). Autophagosomes then undergo a 
maturation process consisting of multiple fusion events with both endosomes and 
lysosomes (Yoshimori 2004; Komatsu et al. 2006; Hara et al. 2006; Nakagawa et 
al. 2004; Ogawa et al. 2005; Ravikumar, Duden, and Rubinsztein 2002; Kamimoto 
et al. 2006; Eskelinen 2005) and their content is digested by lysosomal hydrolases. 
In fact, upon acquisition of lysosomal proteases and the v-ATPase, the interior of 
the autophagosome becomes acidified, and cytoplasmic materials are subjected to 
degradation (Kimura et al. 2007). Autophagosomes at this final stage, after fusion 
with lysosomes, are called autolysosomes (Figure 3).
Autophagy is regulated by more than 30 autophagy-related proteins (Atg), 
many of which have been discovered in yeast (Levine and Klionsky 2004). Most of 
the characterized ATG gene products, including Atg3, Atg5, Atg7, Atg10, Atg12, 
and LC3 (microtubule-associated protein 1 (MAPI) light chain 3), are involved in 
two ubiquitylation-like post-translational modifications of target proteins, which are 
the Atg 12-conjugation and the LC3-modification (Atg8-lipidation in yeast), which 
are essential for the dynamic process of autophagosome formation (Kabeya et al.
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2000; N Mizushima, Noda, et al. 1998; N Mizushima, Sugita, et al. 1998; Noboru 
Mizushima, Ohsumi, and Yoshimori 2002; I Tanida et al. 2001; Isei Tanida et al.
2002). Atg12-conjugation is essential for the formation of pre-autophagosomes, 
whereas LC3-modification is essential for the formation of autophagosomes 
(Kabeya et al. 2000; N Mizushima et al. 2001). Atg12 is activated by the E1 -like 
enzyme Atg7, transferred to the E2-like enzyme Atg10, and conjugated to Atg5 to 
form an autophagosomal precursor (N Mizushima, Noda, et al. 1998; N Mizushima, 
Sugita, et al. 1998; N Mizushima et al. 2001; Noboru Mizushima, Ohsumi, and 
Yoshimori 2002; Nemoto et al. 2003; I Tanida et al. 2001). LC3 is the mammalian 
orthologue of yeast Atg8 and its nascent form, ProLC3, is processed: its carboxyl 
terminal region is cleaved off to become a soluble cytosolic form, LC3-I, exposing a 
carboxyl terminal glicine residue (Kabeya et al. 2000). LC3-I is then activated by 
Atg7, transferred to Atg3, a second E2-like enzyme, modified with 
phosphatidylethanolamine and becomes a membrane-bound form, LC3-II (Tanida 
et al. 2001; Tanida et al. 2002). LC3-II is localized to both the outer and the inner 
membrane of pre-autophagosomes and autophagosomes (Kabeya et al. 2000). 
Following the fusion of autophagosomes with lysosomes, intra-autophagosomal 
LC3-II is degraded by lysosomal hydrolytic enzymes (Kabeya et al. 2000). The 
formation of LC3-II is therefore a good marker to monitor the occurrence of 
autophagosome formation (Kabeya et al. 2000) and thus LC3 is commonly used as 
an autophagosomal marker.
In mammalian cells, autophagy is regulated by nutrient availability and 
hormones, and has been suggested to be essential for cellular homeostasis 
(Kimura et al. 2007). In addition to its homeostatic function, autophagy plays quite
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important physiological roles. In fact, although autophagy is strongly induced under 
conditions of physiological stress, such as starvation, it also occurs at a basal level 
in normal conditions; for example, constitutive autophagy in nutrient-rich conditions 
is involved in intracellular protein quality control, in global turnover of cellular 
components (including organelles) (Komatsu et al. 2006; Hara et al. 2006) and as 
a defense mechanism against bacterial pathogens (Nakagawa et al. 2004; Ogawa 
et al. 2005) or the toxic effects of aggregate-prone proteins (Ravikumar, Duden, 
and Rubinsztein 2002; Kamimoto et al. 2006).
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Figure 3: Schematic diagram of the steps of autophagy.
Autophagy begins with the formation of the phagophore or isolation membrane 
(vesicle nucleation step). The concerted action of the autophagy core machinery 
proteins at the phagophore assembly site is thought to lead to the expansion of 
the phagophore into an autophagosome (vesicle elongation). The autophagosome 
can engulf bulk cytoplasm in a non-specific manner, including entire organelles, or 
target cargos specifically. When the outer membrane of the autophagosome fuses 
with a lysosome (docking and fusion steps), it forms an autophagolysosome, or 
autolysosome. Finally, the sequestered material is degraded inside the 
autophagolysosome (vesicle breakdown and degradation) and recycled.
Model taken from Melendez and Levine, 2009.
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Exocytosis
Lysosomes are also involved in a secretory pathway known as lysosomal 
exocytosis (Figure 1). Exocytosis is the removal of cellular cargo by fusion of 
vesicles with the plasma membrane (PM) (Figure 4). In response to a transient 
increase of cytosolic Ca2+, secretory vesicles move towards the PM, fuse with the 
membrane, and then expel the luminal contents into the external cellular 
environment. Initially, lysosomal exocytosis was considered to be limited to 
specialized secretory cells; in these cells, exocytosis has a housekeeping function 
responsible for the secretion of hormones, cytokines, and neurotransmitter. 
However, several studies indicate that this process occurs in all cell types (N W 
Andrews 2000; Rodriguez et al. 1997; Rodriguez et al. 1999). In fact, it has been 
demonstrated that in non-secretory cells exocytosis plays an important role in PM 
repair (Idone et al. 2008), bone resorption (Smit et al., 2000), cycling/recycling 
proteins to plasma membrane (Catala et al. 2009), pathogen invasion (Imai et al.,
2003), neurite outgrowth (Seiler et al. 2008), and cellular clearance (Pawelek and 
Lerner 1978; Boissy, Zhao, and Gahl 1998). In fact, lysosomes have traditionally 
been viewed as terminal degradative compartments, but they are the most 
important exocytic organelle in non-secretory cells, behaving as Ca2+-regulated 
exocytotic vesicles (Rodriguez et al. 1997).
Lysosomal exocytosis is an ATP- and temperature-dependent process, in a 
way similar to what is known for the classical secretory process (Rodriguez et al.
1997). Lysosomes have exocytic activity, a common feature with synaptic vesicles. 
In fact, they originate from a common early endosome and they also share
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mechanisms of exocytic activation. During the process of the synaptic vesicle 
release, action potentials of neurons reach the presynaptic terminal and activate 
several voltage-regulated Ca2+ channels; this event induces an influx of Ca2+ into 
the presynaptic cytoplasm, the fusion of the synaptic vesicle with the PM and, 
eventually, the release of the neurotransmitter (Nizami et al. 2010). The Ca2+ 
sensor synaptotagmin and the soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor (SNARE) synaptobrevin-2 decorate the synaptic 
vesicles membrane and were found to bind the PM through the corresponding 
SNAREs, syntaxin-1A and synaptosomal-associated protein 25 (SNAP-25), 
respectively (Thorsten Lang and Jahn 2008). The influx of Ca2+ into the cell drives 
interactions between the vesicular and target SNAREs synaptotagmin 7 (SYT7) 
and syntaxin 4 (Thorsten Lang and Jahn 2008), thus inducing lysosomal 
exocytosis.
Moreover, lysosome exocytosis has emerged also as an important 
mechanism for propagating the Ca2+ wave in astrocytes to modulate synaptic 
transmission (Li et al. 2008; Z. Zhang et al. 2007), although on a timescale orders 
of magnitude slower than synaptic transmission.
Lysosomal exocytosis requires two sequential steps. (Figure 4). In the first 
Ca2+-independent step (Jaiswal, Andrews, and Simon 2002), lysosomes are 
recruited to the close proximity of the cell surface. In the second step the pool of 
pre-docked lysosomes fuse with the PM in response to Ca2+ elevation, thus 
emptying their content outside the cell (N W Andrews 2000; Jaiswal, Andrews, and 
Simon 2002; Tucker, Weber, and Chapman 2004).
Taking advantage of exocytosis, lysosomes play a pivotal role in the
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degradation of extracellular matrix (ECM) proteins, cell invasion, and cell migration 
into the ECM (Lakka et al. 2004; Tu et al. 2008).
Exocytosis of lysosomes in response to a transient increase in intracellular 
Ca2+ was first observed in eggs of sea urchin, in which, during the fertilization 
process, thousand of secretory granules are released in response to an increase in 
intracellular Ca2+ concentration (Baker and Whitaker 1980). Furthermore, 
exocytosis, was also observed during cell invasion of Trypanosoma Cruzi: binding 
of the parasite to the cell membrane triggers calcium influx and subsequent fusion 
of lysosomes with the region of the plasma membrane that surrounds the invading 
parasite (Norma W Andrews 2002).
Although the main steps of lysosomal exocytosis have been elucidated, little 
is known about its regulation and how this process is coordinated with lysosomal 
biogenesis.
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Figure 4: Schematic diagram of the steps of lysosomal exocytosis.
Exocytosis is the removal of cellular cargo by fusion of vesicles with the plasma 
membrane (PM). This process requires two sequential steps. (1) In the first Ca2+- 
independent step, lysosomes are recruited to the close proximity of the cell 
surface. (2) In the second step the pool of pre-docked lysosomes fuse with the 
PM in response to Ca2+ elevation, thus emptying their content outside the cell.
Modified from Microbiology: An Evolving Science. Joan L. Slonczewski and John 
W. Foster.
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Lysosomal Storage Diseases
In 1932, Pompe made the crucial observation of extensive glycogen 
accumulation, within membrane-bound vesicles in the heart and skeletal muscles 
of a 7 months old patient who had died from cardiac complications. Based on these 
findings, in 1963 Hers and coworkers deduced the link between the deposition of 
glycogen in Pompe patients and the inherited deficiency of the hitherto unknown 
lysosomal enzyme alfa-D-glucosidase (Hers 1963), identifying the first lysosomal 
disorder. The discovery of the involvement of lysosomes in glycogen degradation 
gave rise to the concept that also other lysosomal storage disorders could be 
explained by specific enzyme deficiencies (Parkinson-Lawrence et al. 2010).
Nowadays, LSDs are a class of metabolic disorders and comprise a group of 
more than 50 different genetic diseases (Wilcox 2004). Despite the large number 
and clinical diversity of lysosomal disorders, these diseases share some common 
features. First, they are typically inherited as autosomal recessive traits (only two 
are X-linked); second, they most commonly afflict infants and young children; third, 
most involve pathology of the brain; and fourth, when brain pathology is present 
they are untreatable (Jeyakumar et al. 2005). Although each of these conditions is 
rare, they exhibit a combined prevalence of 1:5,000 births; some of these disorders 
occur at higher frequency in geographically isolated populations owing to founder 
effects (Dahl, Hillborg, and Olofsson 1993), or in certain ethnic groups in which 
consanguineous marriages are common (Ozkara and Topgu 2004).
LSDs are caused by mutations in proteins critical for lysosomal function. They 
mostly involve the dysfunction of a specific soluble lysosomal hydrolases, which
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result in impaired degradation, substrate accumulation and lysosomal storage 
(Figure 5).
However, lysosomal integral membrane proteins, proteins involved in post- 
translational modifications, in vesicular trafficking and in the biogenesis of 
lysosomal proteins have also been shown to cause storage disorder phenotypes. 
For example, over the last years a number of defects in lysosomal membrane 
proteins have been recognized as the primary cause of lysosomal diseases (Ruivo 
et al. 2009). In fact, lysosomal accumulation can also occur if the correctly 
degraded compound is not properly transported to the cytosol (like in Salla disease 
and in cystinosis).
Other causes of LSDs are deficiencies in membrane-associated enzymatic 
activities (like HSGNAT in mucopolysaccharidosis type III C, MPSIIIC) and 
impairments of ion translocation (like MCOLN1 in mucolipidosis type IV, MLIV). For 
a significant number of LSDs caused by defects in lysosomal membrane proteins, 
the pathogenetic events at a molecular level and also the function of the protein 
under physiological conditions is incompletely understood (Schroder et al. 2010). 
This applies to neuronal ceroid lipofuscinosis (NCL) variants caused by defects in 
the membrane proteins CLN3 (Jalanko and Braulke 2009) and CLN7 (Siintola et al.
2007).
However the biochemical nature of the defects resulting in lysosomal storage 
is very diverse and in many cases the sequence of events leading to lysosomal 
dysfunction is only incompletely understood (Schroder et al. 2010).
In general, LSDs are typically characterized by enlarged lysosomes that 
contain partially degraded material as a result of a deficit in either degradation of
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specific compounds, such as glycosaminoglycans, lipids, or protein, or in transport 
across the lysosomal membrane or in endosome-lysosome trafficking. Any 
disruption of lysosomal function can lead to the accumulation of undegraded 
substrate(s) in endosomes and lysosomes, eventually compromising cellular 
function and ultimately resulting in a complex spectrum of clinical manifestations 
(Hopwood and Brooks 1997).
The accumulation of the primary storage material can cause a chain of 
secondary disruptions to other biochemical and cellular functions, which leads to 
the severe pathology observed in LSDs (Parkinson-Lawrence et al. 2010). Once 
material starts to accumulate, it builds up within lysosomes until the lysosomal 
burden of the cell reaches some maximum level, at which point storage material 
starts to accumulate in other parts of the cell (Jeyakumar et al. 2005). The 
accumulation of undigested molecules can subsequently alter many cellular 
processes, including lysosomal pH regulation, synaptic release, endocytosis, 
vesicle maturation, autophagy, exocytosis and Ca2+ homeostasis (Vitner, Platt, and 
Futerman 2010; Bellettato and Scarpa 2010; Ballabio and Gieselmann 2009; 
Bezprozvanny 2009). It is still undefined whether the storage material affects cell 
function only when it begins to accumulate in extra-lysosomal sites or if problems in 
cell homeostasis are triggered while the material is still confined to the lysosome 
(Jeyakumar et al. 2005).
The accumulation of the primary storage material can also have a functional 
impact on the cell, including the inhibition of other enzymatic processes, causing 
the accumulation of secondary undegraded substrates and the disruption of 
lysosomal biogenesis (Parkinson-Lawrence et al. 2010).
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Clinically, LSDs are associated with a progressive phenotype involving 
multiple organs and tissues (Settembre et al. 2008).
Although lysosomal proteins are ubiquitously distributed, the accumulation of 
undegraded substrate(s) in LSDs patients is normally restricted to those cells, 
tissues, and organs in which substrate turnover is high (Parkinson-Lawrence et al.
2010). However, the Central Nervous System (CNS) is particularly affected in LSD 
patients; over two-thirds of LSDs involve CNS dysfunction, like progressive 
cognitive and motor decline, and these symptoms are often the most debilitating 
(Schultz et al. 2011). In the CNS, the progressive accumulation of undegraded 
material induces a series of secondary defects, eventually leading to severe 
neurodegeneration.
Storage may begin during early embryonic development, and the clinical 
presentation for LSDs can vary from an early and severe phenotype to late-onset 
mild disease (Filocamo and Marrone 2011). However, although individuals affected 
by LSDs can display early symptoms, many are clinically normal at birth and 
typically meet early developmental milestones, indicating that lysosomal storage 
does not affect neuronal function and maturation at early developmental stages. In 
general, this suggests that lysosomal dysfunction per se does not impact 
significantly the complex events of early brain development, such as neural 
induction, establishment of axis, neuronal differentiation and migration, and 
synapse formation (Schultz et al. 2011).
Several systems for the classification of LSDs have been proposed. Most 
simply the diseases are grouped according to the nature of the storage material -  
either regarding biochemical composition or morphological appearance -  in
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mucopolysaccharidoses, glycoproteinoses, (sphingo)lipidoses, glycogen storage 
diseases and neuronal ceroid lipofuscinoses.
Although individual LSDs are rare, as group they are one of the most common 
genetic disorders in children, affecting 1 out of every 7000-8000 live births.
Many of the phenotypes observed in LSDs can be markedly improved by 
substrate reduction therapy (SRT), enzyme replacement therapy (ERT) or gene 
therapy, whose efficacy can be monitored by concomitant resolution of storage 
material (Eng et al. 2001, 200; Liu et al. 2005). In fact, storage burden in tissue 
sections or body fluids can be used as a reliable indicator of therapeutic efficacy in 
emerging treatment strategies for some LSDs (Eng et al. 2001; Schultz et al. 
2011).
However, the progressive lysosomal accumulation of undegraded metabolites 
results in generalized cell and tissue dysfunction, and, therefore, in a multi- 
systemic pathology (Filocamo and Morrone 2011); thus, such treatments are not 
yet available or feasible for most LSDs. Therefore, understanding how the affected 
cellular pathways interconnect and impact the viability of cells is critical for future 
therapeutic development (Schultz et al. 2011).
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Figure 5. Schematic diagram illustrating the pathogenesis of lysosomal 
storage diseases.
A complex substrate is normally degraded by a series of lysosomal enzymes (A, 
B, and C) into soluble end products. If there is a deficiency or malfunction of one 
of the enzymes (e.g., B), catabolism is incomplete and insoluble intermediates 
accumulate in the lysosomes.
Modified from Kumar: Robbins and Cotran Pathologic Basis of Disease
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Multiple Sulfatase Deficiency
Among acid hydrolases acting within the lumen of lysosomes, sulfatases are 
a family of enzymes that share both structural and functional similarities. They are 
involved in a number of different biological functions as diverse as degradation of 
complex molecules, production of steroid hormones and cell signalling. In 
particular, they catalyze the hydrolysis of sulfate ester bonds from a wide variety of 
substrates, ranging from complex molecules, such as GAGs, to sulfolipids and 
steroid sulfates. These enzymes can be divided, at least in mammals, into two 
main categories based on their subcellular localization: those acting at an acidic 
pH, localized in the lysosomes, and those acting at a neutral pH that are found in 
the ER, in the Golgi apparatus, and at the cell surface (Hanson, Best, and Wong 
2004; Parenti, Meroni, and Ballabio 1997) (Hopwood and Ballabio, 2001).
MSD is an extremely rare autosomal recessive disorder, with an incidence of 
1:1,400,000 and characterized by a dramatic impairment of all sulfatase activities. 
Life expectancy for MSD patients is commonly under 10 years of age.
Almost two decades ago it was demonstrated that sulfatases undergo a 
unique post-translational modification, which is indispensable for their enzymatic 
activity (Schmidt et al. 1995). This modification involves a highly conserved 
cysteine residue (Cys), located within the active site of sulfatases, which is 
modified into a formylglycine residue (FGIy). The gene encoding the enzyme 
involved in the post-translational modification of sulfatases was identified and found 
to be mutated in patients with MSD (Cosma et al., 2003; Dierks et al., 2003). The 
MSD causing gene is called SUMF1 and encodes a formylglycine-generating
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enzyme (FGE) (Figure 6). SUMF1 exerts its activity within the ER; however, it can 
also be secreted and taken up by distant cells and tissues, where it relocalizes in 
the ER as an active enzyme (Zito et al. 2007). In MSD patients residual sulfatase 
activities are substantially reduced (Dierks et al. 2003; Cosma et al. 2003), but still 
detectable at variable levels, indicating that MSD is caused by hypomorphic 
mutations in SUMF1 gene and that the complete loss of SUMF1 function is likely to 
be lethal in humans (Cosma et al. 2003). Interestingly, the phenotype of MSD 
patients combines, with some phenotypical variability, all the clinical symptoms 
observed in each individual sulfatase deficiency (Bischel, Austin, and Kemeny 
1966). As a major sign they show a neurodegenerative course of disease with loss 
of sensor and motor abilities and neurological deterioration. Mental retardation, 
hepatosplenomegaly, shortening of stature and corneal clouding appear like in 
different mucopolysaccharidoses.
In the past years, in our laboratory, a mouse line carrying a null mutation in 
the SUMF1 gene has been generated using a gene-trapping approach (Settembre 
et al. 2007). In these mice, the function of the entire sulfatase protein family has 
been completely abolished, mimicking the phenotype observed in MSD patients: 
massive accumulation of undegraded molecules, systemic inflammation and 
neurodegeneration. Moreover, the phenotype of these mice is severe and 
progressive; they display frequent early mortality (only the 10% reaches the age of 
3 months), congenital growth retardation, skeletal abnormalities (including the 
typical flat facial appearance) and tremor and seizures due to defects of the CNS. 
Many tissues were examined for the presence of storage material, which was 
shown to increase with age; glycosaminoglycan accumulation was detected in liver,
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kidney and, as a prime site, in macrophages which were massively present in all 
tissues. These macrophages and activated microglia in cerebellum and cortex, 
accompanied by neuronal cell loss and astroglyosis, indicate systemic 
neuroinflammation, which are thought to be key patho-physiological processes in 
MSD (Settembre et al. 2007).
In addition, nutrient-starved MSD mouse primary cells, as well as other 
monogenic LSDs, such as the Sanfilippo syndrome, or mucopolysaccharidosis type 
III A (MPSIIIA), present a block of autophagy as a consequence of decreased 
ability of lysosomes to fuse with autophagosomes; this leads to accumulation of 
toxic substrates, such as poly-ubiquitinated proteins and dysfunctional 
mitochondria, which are the putative mediators of cell death (Settembre et al. 
2008).
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Figure 6. Mutations in the suifatase-modifying factor-1 (SUMF1) gene result 
in the production of defective C-formylglycine-generating enzyme (FGE).
Defective FGE cannot convert the cysteine (Cys) residue in the active site of 
lysosomal sulfatases to formylglycine (FGIy). As a consequence, inactive 
sulfatases are transported to the lysosome, where they are unable to degrade 
their substrate, leading to their accumulation and subsequently to MSD pathology.
Model taken from Futerman and van Meer, 2004
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LSDs and autophagy
In the past years there has been an increased interest in investigating the 
possible involvement of autophagy in LSD pathogenesis (Cao et al. 2006; Koike et 
al. 2005; Fukuda et al. 2006; Jennings et al. 2006; Settembre et al. 2008). In our 
laboratory, we study two mouse models of neurodegenerative LSDs, MSD and 
MPSIIIA. Cells from both of these LSD models display: (1) increased numbers of 
autophagosomes, (2) reduced clearance of both endogenous and exogenous 
autophagic substrates and (3) defective organelle turnover (Settembre et al. 2008).
Interestingly, alterations in the autophagic/lysosomal pathway have been 
observed in more common multifactorial diseases (Levine and Kroemer 2008), 
such as Parkinson’s disease (PD) (Pan et al. 2008; Ramirez et al. 2006) and 
Alzheimer’s diseases (AD) (Nixon 2007), many forms of cancer (Kirkegaard 2009) 
and atherosclerosis (Martinet and De Meyer 2008). It is often not clear if the 
observed alterations represent causes or secondary consequences of the disease 
process.
Reports demonstrating that genetic disruption of autophagy causes 
neurodegeneration in mice (Hara et al. 2006; Komatsu et al. 2006) led to the 
hypothesis that the neurodegeneration in LSDs might be a consequence of 
impaired autophagy. Indeed, impaired autophagy has been reported also in other 
models of LSDs, including Pompe disease, Niemann-Pick disease (NPC), NCLs, 
MLIV, and GM1 -gangliosidosis (Cao et al. 2006; Fukuda et al. 2006; Jennings et al. 
2006; Pacheco, Kunkel, and Lieberman 2007; Venkatachalam et al. 2008).
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LSDs and exocytosis
Lysosomal function is intimately linked to exocytosis, and several LSDs.
An example is MLIV; when human MLIV fibroblasts are treated with 
ionomycin to elevate intracellular levels of Ca2+ and induce lysosomal exocytosis, 
the release of soluble lysosomal enzymes in the extracellular space is strongly 
reduced compared to healthy fibroblasts, suggesting that MCOLN1 plays an 
important role in this process (LaPlante et al. 2006). Further, transfection with wild- 
type MCOLN1 cDNA rescues exocytosis, suggesting the possibility of treatments 
based on the restoration of this crucial cellular function (LaPlante et al. 2006).
Another example is Niemann-Pick disease type 1 (NPC1); in fibroblasts 
derived from mouse models, cholesterol accumulation inhibits Rab guanosine 
triphosphatases (GTPases), thus perturbing membrane recycling; overexpressing 
Rab4 in these cells led to an activation of exocytosis and reduced lysosomal 
accumulation (Choudhury et al. 2004). Thus, enhancing exocytosis can not only 
reduce the storage burden, but also improve secondary phenotypes.
Transcriptional regulation of lysosomal biogenesis
A commonly reported observation in several LSDs is a decrease in the 
activity of a disease-associated enzyme are concomitant with increases in other 
lysosomal enzymes, suggesting that gene expression required for their 
interdependence is similarly orchestrated (Schultz et al. 2011). On the other hand, 
it has been shown that expansion of the lysosomal compartment, which is a
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common feature of all LSDs, is usually accompanied by increased activity (and 
release) of many lysosomal proteins (Moran et al. 2000). Thus, a coordinated 
control mechanism with enhanced transcriptional expression was long suspected.
Recently in our laboratory it was observed, by using the gProfiler tool 
(Reimand et al. 2007), that genes encoding lysosomal proteins (hereafter referred 
to as lysosomal genes) tend to have coordinate expression. Furthermore, in most 
of them is present a common palindromic motif, which was named Coordinated 
Lysosomal Expression and Regulation (CLEAR) and which mediates their 
transcriptional activation (Sardiello et al. 2009). The CLEAR motif is a 10-base pair 
neucleotidic sequence (GTCACGTGAC), which is placed near the transcription 
start site of many lysosomal genes and is the target site of the bHLH transcription 
factor TFEB (Figure 7). It was found that most lysosomal genes share one or more 
copies of the regulatory motif in their promoters. The CLEAR network is comprised 
of several classes of genes, including genes that belong to the lysosomal 
complement (hydrolases, transporters, accessory proteins) and genes that 
participate in lysosomal biogenesis and function. Examples of the latter class are 
genes encoding subunits of the vacuolar proton pump, responsible for creating and 
maintaining the lysosomal acidic environment, and genes coding for the 
specialized transporters that import acid hydrolases into the lysosome.
It was observed that TFEB overexpression not only increases the number of 
lysosomes in the cell, but also improves cellular degradative capabilities. In fact, it 
was tested the clearing potential of TFEB on a neuronal cell model of Huntington’s 
disease (HD), and found that TFEB transfection increased the clearance of the 
pathogenic polyglutamine-expanded huntingtin (Sardiello et al. 2009). These data
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uncovered a regulatory network defining TFEB as a master regulator of lysosomal 
biogenesis. Furthermore, in cultured cell models of mucopolysaccharidosis type II 
(MPSII), MPSIIIA, and MSD, TFEB localizes primarily in the nucleus, but is 
cytoplasmic in control cells, suggesting that this pathway is activated under 
lysosomal storage conditions (Sardiello et al. 2009).
The observation that the process of lysosomal degradation is transcriptionally 
regulated raised the hypothesis that other lysosomal-related processes, like 
autophagy, might also be transcriptionally regulated by the same mechanism. In 
principle, enhancement of lysosomal function should result in a decrease in the 
number of autophagosomes due to increased degradation, whereas the opposite 
should occur in the presence of lysosomal inhibitors. However, it was observed that 
TFEB overexpression increases the number of autophagosomes and, conversely, 
RNA interference of TFEB decreases the number of autophagosomes, suggesting 
a role of TFEB in the regulation of the autophagic process as well (Settembre et al.
2011).
Interestingly, the fact that TFEB also regulates key autophagy switches 
indicates that the CLEAR network extends beyond the lysosomal complement to 
favor lysosome-dependent degradative pathways as a whole (Sardiello and 
Ballabio 2009).
Moreover, it was also hypothesized that TFEB may mediate starvation- 
induced autophagy. Interestingly, it was observed that upon starvation TFEB 
translocates from the cytoplasm (where it normally resides) to the nucleus where it 
is active and regulates the expression of its target genes (Settembre et al. 2011). 
This translocation occurs in a phosphorylation-dependent manner. In fact, it was
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demonstrated that TFEB is maintained inactive in the cytoplasm through its 
phosphorylation on a critical serine residue (Ser142), and then it translocates to the 
nucleus when dephosphorylated (Settembre et al. 2012).
In particular, it was also shown that TFEB phosphorylation occurs on the 
lysosomal membrane by the master growth regulator, mammalian target of 
rapamycin (mTOR) complex 1 (mTORCI) (Settembre et al. 2012). Therefore, it 
was proposed the hypothesis that under full nutrients and in the absence of 
lysosomal stress the interaction between the lysosomal amino acid content and the 
v-ATPase complex, involved in lysosomal acidification, regulates Rag GTPases, 
which in turn activate mTORCI by translocating it to the lysosomal surface 
(Sancak et al. 2008; Zoncu et al. 2011). At the lysosome, mTORCI binds and 
phosphorylates TFEB, therfore controlling its subcellular localization and its 
inactive state. Indeed, phosphorylation by mTORCI maintains TFEB in the 
cytoplasm and prevents it from translocating to the nucleus. Starvation, v-ATPase 
inhibition, or lysosomal stress switch the Rags off, leading to mTORCI detachment 
from the lysosome and to its inactivation. TFEB can no longer be phosphorylated 
and thus it translocates to the nucleus, where it activates gene expression 
programs that boost lysosomal function and autophagy. These data demonstrated 
that TFEB mediates starvation-induced autophagy (Settembre et al. 2012).
Therefore, TFEB acts both as a sensor of lysosomal state, when on the 
lysosomal surface, and as an effector of lysosomal function when in the nucleus. 
This unique lysosome-to-nucleus signalling mechanism allows the lysosome to 
regulate its own function (Settembre et al. 2012).
41
10
8
6
noui/)
CDO
0>cn
c
rojru
525
1
0,8
0.6
2  0.4
0.2
0.1
I TFEB overexpression  
•TFEB silencing
■ ■ h ■ ■
P£
uj 3:
§ 5X tnCQGu-<:
QC QC I—  --- -n:u
DQ
U")s< £
, 9 :  r r i  t ?  Q .. m  £  ■•
Lysosomal genes
£
O . ' t O ?  *^<*5 IN P F~ Q- c >< 55 C£2jP iij ^  
cxvd cq O
>t (j c  a :  i 2 S ; S : O i n  
Controls
B Empty TFEB/ vector GFP - TFEB/ GFP +
A C TIN
1.2
<: o.6
TFEB/Empty
vector
TFEB/ 
GFP +
iG-TFEB
V
V
MERGE
\"<? 
^  \
Figure 7. TFEB controls the expression of lysosomal genes and enhances 
cellular clearance.
(A) Expression analysis of lysosomal genes following TFEB overexpression and 
silencing. Blue bars show the fold change of the mRNA levels of lysosomal genes 
in TFEB- vs. pcDNA3-transfected cells. Red bars show the fold change of mRNA 
levels in mimic-miR-128-transfected cells vs. cells transfected with a standard 
control microRNA (mimic-miR-cel-67). (B) Immunoblot analysis of TFEBEGFP- 
positive (+) and TFEB-EGFP-negative (-) HD43 cells (left panel) and 
immunofluorescence analysis of TFEB and HTT in HD43(Q105) cells transfected 
with 3xFLAG-TFEB construct (right panel).
Taken from Sardiello et al., 2009
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Neural Stem Cells
Stem cells are undifferentiated cells that are capable of giving rise to 
indefinitely more cells of the same type, and from which certain other types of cell 
arise by differentiation. Indeed, stem cells exhibit two defining characteristics: the 
self-renew, which is the ability to go through numerous cycles of cell division while 
maintaining the undifferentiated state, and the potency, which is the capacity to 
generate a diverse range of specialized cell types through differentiation (Gage
2000).
There are two types of mammalian stem cells: embryonic and adult. 
Embryonic tern cells (ESCs) derive from the inner cell mass of the blastocyst and 
are totipotent, which means that they can differentiate into all of the specialized 
embryonic tissues. Adult stem cells are found in adult tissues and act as a repair 
system for the body, replenishing specialized cells, but also maintaining the normal 
turnover of regenerative organs; unlike ESCs, they are often restricted to certain 
lineages (for exemple hematopoietic or neural fate) (Figure 8).
NSCs are self-renewing multipotent populations present in the developing and 
adult mammalian CNS (Chojnacki and Weiss 2008; Temple 2001). During the 
process of neurogenesis, NSCs generate the neurons and glia of the developing 
brain and also account for the limited regenerative potential of the adult brain.
Neurogenesis is the process of generating functional neurons from precursors 
and in mammals it begins with the induction of the neuroectoderm, which forms the 
neural plate (at embryonic day 7.5 (E7.5) in mice) and then folds to give rise to the
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neural tube (at E8.5 in mice). These structures are made up by a layer of so-called 
neuroepithelial progenitors (NEPs) (Gotz and Barde 2005), which are probably a 
complex and heterogeneous population. During this neural differentiation, ESCs 
undergo progressive lineage restrictions, leading to the generation of a range of 
distinct neural precursor populations that can be used to study the molecular and 
cellular events that occur during stage-specific transitions between different 
populations (Nishikawa, Jakt, and Era 2007; S.-C. Zhang 2006, 200).
Neurogenesis was traditionally viewed to occur only during embryonic and 
perinatal stages in mammals (Ming and Song 2005). Nevertheless, Altman's 
pioneering studies decades ago provided the first anatomical evidence for the 
presence of newly generated dentate granule cells in the postnatal rat 
hippocampus (Altman and Das 1965). Multipotent neural stem cells were later 
derived from the adult mammalian brain (Reynolds and Weiss 1992; Richards, 
Kilpatrick, and Bartlett 1992). Since then, significant progress has been made over 
the past decades in the study of almost every aspect of adult neurogenesis in the 
mammalian CNS.
In general, adult neurogenesis recapitulates the complete process of neuronal 
development in embryonic stages, but is spatially restricted under normal 
conditions to two specific “neurogenic” brain regions: the subgranular zone (SGZ) 
in the dentate gyrus of the hippocampus, where new dentate granule cells are 
generated, and the subventricular zone (SVZ) of the lateral ventricles in the 
forebrain, where new neurons are generated and then migrate through the rostral 
migratory stream (RMS) to the olfactory bulb to become interneurons (Gage 2000; 
Ming and Song 2011).
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In the adult SGZ, proliferating radial and non-radial precursors give rise to 
intermediate progenitors, which in turn generate neuroblasts. Immature neurons 
migrate into the inner granule cell layer and differentiate into dentate granule cells 
in the hippocampus (Ming and Song 2012).
In the adult SVZ, proliferating radial glia-like cells give rise to transient 
amplifying (TA) cells, which in turn generate neuroblasts. In the RMS, neuroblasts 
form a chain and migrate toward the olfactory bulb through a tube formed by 
astrocytes (Lois, Garcia-Verdugo, and Alvarez-Buylla 1996). Once reaching the 
core of the olfactory bulb, immature neurons detach from the RMS and migrate 
radially toward glomeruli where they differentiate into different subtypes of 
interneurons (Lledo, Alonso, and Grubb 2006).
Therefore, the SGZ and the SVZ are the two main niches that in vivo support 
self-renewal and regulate the balance between symmetrical self-renewal, by which 
NSCs proliferate, and fate-committed asymmetrical division, by which NSCs 
generate differentiated cells (Alvarez-Buylla and Lim 2004; Garcion et al. 2004; 
Shen et al. 2004; Shen et al. 2008). In fact, niches are defined as 
microenvironments that anatomically house stem cells and functionally control their 
development in vivo.
The size of the NSC pool in the SVZ is much larger than that in the SGZ (Lois 
and Alvarez-Buylla 1993; Morshead et al. 1994).
Due to the constitutive migration and high proliferation rate of neural 
progenitor cells in the SVZ (Lucassen et al. 2010; Curtis, Kam, and Faull 2011), it 
has been proposed that the neuronal differentiation of NSCs in the SVZ might be 
particularly important for the autonomous repair of the brain during the
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pathogenesis of a disease. In fact, studies based on animal disease models 
revealed that neural progenitor cells in the SVZ can also migrate to regions where 
neuronal disorders occur to compensate for the loss of living neurons (Arvidsson et 
al. 2002; Tattersfield et al. 2004).
The proliferation and differentiation of NSCs are strictly regulated by a 
complex regulatory system, including a variety of intrinsic and extrinsic 
mechanisms, such as morphogens and growth factors, as well as transcription 
factors and epigenetic mechanisms. Morphogenic proteins and transcription factors 
are the fundamental forces that determine the fate of NSCs and the process of 
neurogenesis. Morphogens are a group of proteins that not only are vital for the 
embryonic development and patterning of the brain, but also function to regulate 
the self-renewal and differentiation of NSCs in the adult brain. This group of 
proteins includes Notch, sonic hedgehog (Shh), wingless-type MMTV integration 
site family (Wnt), fibroblast growth factor (FGF), and bone morphogenetic proteins 
(BMPs). During the process of embryonic development, ESCs in the ectoderm 
differentiate into excitatory and inhibitory neurons. These morphogenetic proteins, 
combined at different concentrations, act to pattern the brain along the anterior- 
posterior and dorsal-ventral axis into different regions. For instance, FGF is 
responsible for the anterior-posterior patterning and BMP and Shh are specific for 
the dorsal-ventral patterning; Wnt contributes to both processes. In the adult brain, 
the morphogenic proteins continue to subtly modulate the number and 
differentiation of neural precursor cells. In both the SGZ and the SVZ, Shh is 
essential for the maintenance of radial glia-like cells (Ahn and Joyner 2005; Balordi 
and Fishell 2007; Han et al. 2008), whereas Notch is fundamental for the neuronal
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differentiation of NSCs (Imayoshi et al. 2010; Pierfelice, Alberi, and Gaiano 2011). 
Wnt can also promote the neuronal differentiation of NSCs in the SGZ (Lie et al. 
2002), whereas BMP determines their glial fate (Urn et al. 2000; Bonaguidi et al. 
2005; Mira et al. 2010).
The concurrent action of these morphogens via a concentration gradient 
leads to the differentiated expression of hundreds of transcription factors to 
determine the fate of newborn neurons. However, limited information is available 
on the roles that transcription factors play in NSC differentiation in the adult brain, 
and only a handful of transcription factors have been extensively studied. One such 
factor is Sox2, which is present in both the SGZ and SVZ, and colocalizes with 
NSC markers glial fibrillary acidic protein (GFAP), nestin, brain lipid-binding protein 
(BLBP), and Musashi-1 (Ferri et al. 2004, 200; Komitova and Eriksson 2004; Suh 
et al. 2007; Lugert et al. 2010). Evidence based on transgenic mice revealed that 
Sox2 acts probably through an interactive regulation with Notch signaling 
(Taranova et al. 2006; Ehm et al. 2010). Another well-studied transcription factor is 
Pax6, which is expressed in NSCs in the SGZ (Maekawa et al. 2005; Nacher et al. 
2005; Hodge et al. 2008; Roybon et al. 2009) and in neuroblasts in the SVZ 
(Herold et al. 2011; Jones and Connor 2011) and functions to promote the 
dopaminergic fate determination of NSCs (Kohwi et al. 2005; Brill and Huguenard 
2008; Spitere et al. 2008).
On the other hand, abundant evidence supports the finding that NSC 
differentiation and proliferation in the adult SVZ and SGZ is closely regulated by the 
local environmental factors, such as surrounding neurons, astrocytes, and other 
non-neuronal cells (Suh, Deng, and Gage 2009), either in an activity relevant
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manner or through growth factor release.
In general, endogenous NSCs in their undifferentiated state are recognized 
for the expression of the nestin marker. The neural specific intermediate filament 
nestin, in fact, is utilized to visualize the regions of neurogenesis throughout the life 
of the animals. Cells that are immunoreactive for nestin are thought to be involved 
in neurogenesis (Doyle, Khan, and Cunningham 2001; Yue et al. 2006), and 
therefore to differentiate into neurons and glial cells (Itoh et al. 2006). During brain 
development, nestin is expressed by radial glia cells, and nestin expression starts 
to disappear around postnatal day 11 (P11) in the rat cortex (Kalman and Ajtai
2001). Based on these data, nestin might provide an ideal marker to examine 
neurogenesis within the adult brain.
During the development of the CNS, NSCs are precursors of glia and 
neurons, both characterized by the expression of their own specific markers, GFAP 
and neuron specific class III (B-tubulin (Tuj 1), respectively.
GFAP is widely known as a marker for mature astrocytes in the adult brain. A 
large proportion of the newborn cells in the SGZ of the hippocampal region have 
also been found to be GFAP-positive (Eckenhoff and Rakic 1988; Maslov et al.
2004). However, the use of GFAP as a marker for neurogenesis is hampered by 
the finding that the glial cell lineage and mature astrocytes are also labeled. Thus, 
the nestin-positive, but not the GFAP-positive, precursors are the precursors 
involved in neurogenesis (Cao et al. 2006).
Tuj1 expression starts as early as embryonic day 8.5 (Easter, Ross, and 
Frankfurter 1993) and can be detected throughout brain development (Menezes 
and Luskin 1994). Tuj1 has been found to label newly generated immature
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postmitotic and differentiated neurons (Menezes and Luskin 1994). With respect to 
adult neurogenesis, Tuj1 is used as a neuron-specific marker of newly generated 
cells (F Doetsch, Garcia-Verdugo, and Alvarez-Buylla 1997; Gould et al. 2001).
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Figure 8. Schematic diagram illustrating lineage commitment of adult neural 
stem cells.
Pluripotent ESCs can form any body tissue (except for the placenta). During 
development, cells derived from these stem cells become progressively more 
specialized, like NSCs that are multipotent precursors of the two main cell type of 
CNS, glia and neurons.
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Isolation of adult Neural Stem Cells
Isolation of NSCs from their adult natural niche and their purification and 
expansion have been problematic, as the factors and cell contacts required to 
maintain these cells in their physiological state are poorly understood (Conti and 
Cattaneo 2010). However, epidermal growth factor (EGF) and FGF2 have been 
key players in the identification of cell culture conditions that sustain prolonged cell 
division of cells with NSC properties (Reynolds and Weiss 1992; Reynolds and 
Weiss 1992; Laywell, Kukekov, and Steindler 1999).
Two main strategies have been developed for NSC isolation and in vitro long­
term propagation, the neurosphere system and the monolayer system.
Neurosphere system
Neurospheres are free-floating aggregates of neural progenitors, each 
potentially derived from a single NSC (Reynolds and Weiss 1992; Reynolds, 
Tetzlaff, and Weiss 1992; Laywell, Kukekov, and Steindler 1999). Their generation 
relies on tissue microdissection followed by exposure to mitogens (Chojnacki et al.
2008). Commonly, mouse and rat neurospheres are harvested from neural tissue 
at E10.5-E18.5 or from the adult SVZ (F Ciccolini 2001; Francesca Ciccolini et al. 
2005; F Ciccolini and Svendsen 1998; Gritti et al. 1995; Louis and Reynolds 2005; 
Svendsen et al. 1998; Tropepe et al. 1999; Uchida et al. 2000). For their 
expansion, cells are plated in low-attachment tissue culture plastic dishes in serum- 
free media supplemented with EGF (10-20 ng per ml) and/or FGF2 (10-20 ng per
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ml) (Singec et al. 2006). In these conditions, most differentiating or differentiated 
cells are expected to die, whereas the NSCs respond to the mitogens, divide and 
form floating aggregates (primary neurospheres) that can be dissociated and re­
plated to generate secondary neurospheres. This procedure can be repeated 
several times to expand a NSC population.
Neurospheres have been used in vitro for defining, by extrapolation, the 
persistence and properties of NSCs in vivo (Golmohammadi et al. 2008; Marshall, 
Reynolds, and Laywell 2007). In fact, the cellular milieu of the neurosphere has 
been suggested to provide an in vitro counterpart to the in vivo neurogenic 
compartment, a microenvironment that is relevant for NSC maintenance, 
proliferation and differentiation. The concept of a neurosphere as an in vitro 
recapitulation of a niche-like structure has become extremely popular in the NSC 
field (Conti and Cattaneo 2010). The regulation of stem cell features in the niche 
requires both interactions between stem cells and interactions between stem cells 
and neighbouring differentiated cells, mediated by soluble and adhesion molecules 
and extracellular matrix components (Conti and Cattaneo 2010).
However, it has been demonstrated the tendency of neurospheres to 
generate differentiated cells in their core (Campos 2004), since different cells in the 
sphere can be exposed to suboptimal conditions due to their three-dimensional 
structure. Consequently, the interaction between differentiating cells and precursor 
cells may expose the NSCs to paracrine factors that promote differentiation. 
Therefore, the maintenance of the neurogenic versus gliogenic potential gradually 
declines with in vitro passages (Conti and Cattaneo 2010). Hence, neurospheres 
can be considered as the in vitro counterpart of the in vivo niche structure only for a
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limited time after brain dissection.
Different neuronal differentiation protocols based on mitogen removal and 
exposure to fetal bovine serum and/or to specific substrates and cytokines have 
been developed (Garcion et al. 2004; Chojnacki and Weiss 2008; Tropepe et al. 
1999; Grandbarbe et al. 2003; Weiss et al. 1996), but none of them generates cells 
that are positive for the early neuronal marker Tuj1 at a proportion greater than 
20%. On the whole, this suggests that the neurosphere system is not particularly 
efficient in terms of neurogenic competence, but it can be useful for studying self- 
renew abilities and proliferation capacities of NSCs after tissue dissociation.
Monolayer system
Early attempts to culture NSCs in monolayer conditions relied on plating them 
on polyornithine-, laminin- or fibronectin-coated dishes in serum-free media (Johe 
et al. 1996) and in the presence of morphogens (Palmer, Takahashi, and Gage 
1997). These cells show homogeneity for nestin and Sox2 expression, and 
symmetrical cell division continuously replenishes the supply of multipotent 
progenitors.
More recently, other strategies for the derivation and stable long-term 
propagation of NSC lines from different sources of rodent (Conti et al. 2005; Pollard 
et al. 2006, 200) and human (Sun et al. 2008) origin have been described. 
According to these procedures, neural precursors can be competently expanded as 
adherent, clonal, uniform NSC lines by exposure to EGF and FGF2 (Elkabetz et al. 
2008; Koch et al. 2009; Conti et al. 2005). Under these conditions cells divide
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symmetrically, retaining their tripotential differentiation capacity, indicating that 
monolayer culture systems can maintain almost pure NSC populations (Conti et al.
2005), with a negligible differentiated component. The key aspect of the NSC 
culture system lies in the combination of EGF and FGF2 used and the focus on 
cells that grow adherently. The continuous provision of EGF together with FGF2 
seems to be essential for the derivation and propagation of these monolayer- 
growing NSCs (Palmer, Takahashi, and Gage 1997). When grown in these 
conditions, NSC population shows a remarkable antigenic similarity to forebrain 
neurogenic radial-glia (RG) (Conti et al. 2005; Pollard et al. 2006). The fact that 
NSCs can also be established from long-term expanded neurospheres indicates 
that RG-like cells might be the NSC fraction in neurospheres and that monolayer 
growth conditions may allow their enrichment and subsequent expansion (Conti et 
al. 2005).
Interestingly, cells in these EGF- and FGF2-dependent monolayers retain 
multipotency and neurogenic efficiency also after prolonged in vitro expansion and 
show a high competence to efficiently originate antigenically and 
electrophysiologically mature neurons on exposure to optimized differentiating 
conditions (Koch et al. 2009; Conti et al. 2005; Spiliotopoulos et al. 2009; Goffredo 
et al. 2008). This capacity can probably be interpreted as a consequence of the 
homogeneity of the starting population.
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AIM
The main objective of the research described in this thesis is to establish a 
cellular system to study the mechanisms of neurodegeneration in MSD pathology. 
This in vitro system must resemble the main hallmarks of the disease, such as the 
primary accumulation of undegraded substrates, secondary accumulation of 
undigested substrates, impaired autophagy and increased apoptosis.
Although cell death characterizes the later stages of the disease, for most of 
the clinical course the pathology mainly involves neuronal dysfunction rather than 
loss. Therefore, the ultimate goal will be to elucidate the intracellular mechanisms 
that lead to neuronal dysfunction after the pathologic accumulation of undegraded 
substrates.
Therefore, my thesis project aimed firstly at the isolation and characterization 
of NSCs from MSD and wild-type adult mice. For this purpose, I successfully built a 
robust protocol to isolate NSCs from postnatal brain tissue; once established in 
culture, I defined the progenitor identity of these cells. In order to assess whether 
NSCs could be a reliable tool to clarify the mechanisms of neurodegeneration in 
MSD pathology, I focused on the characterization of MSD-NSCs and on 
investigating whether they also reflect the main hallmarks of the disease, such as 
the progressive accumulation of undegraded GAGs, impaired autophagy and high 
levels of apoptosis, as seen in adult mice.
Furthermore, establishing an in vitro system that recapitulates the main 
hallmarks of LSDs would be useful also to identify relevant pathogenic intracellular
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pathways leading to the developing of new therapeutics strategies for the treatment 
of MSD, as well as other neurodegenerative LSDs. An intriguing therapeutic 
strategy that allows us to test our in vitro system came from studies carried out in 
our laboratory on the transcription factor TFEB, a master gene for lysosomal 
biogenesis and function. TFEB overexpression is able to reduce mutant huntingtin 
in a cellular model of HD (Sardiello et al. 2009). It was shown that TFEB is able to 
increase the capacity of the lysosome to degrade by increasing the bulk of 
lysosomal components. Therefore, we tested the role of TFEB in the clearance of 
pathologic undegraded substrates in isolated MSD-NSCs. Surprinsingly, we found 
that TFEB overexpression is able to reduce primary accumulation of GAGs in 
differentiated MSD-NSCs by inducing lysosomal exocytosis (Medina et al. 2011). 
Therefore, our studies envisage a novel tool, by targeting lysosomal exocytosis 
mechanism, to reduce the lysosomal burden in storage diseases.
To achieve all these objectives, I selected the following main goals:
(1) isolation and characterization of NSCs from MSD mice;
(2) phenotyping of MSD-NSCs to investigate the intracellular cascades involved 
in neurodegeneration;
(3) modulating lysosomal function as a novel tool to treat LSDs.
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RESULTS
Isolation of NSCs from post-natal brain of wild-type and MSD mice
The crucial point of this research project is the isolation of NSCs from the 
brain of postnatal wild-type and MSD mice. Recently, it has been established a 
methodology that allows for the isolation and continuous ex vivo expansion of 
NSCs from mouse brain tissue that can be easily cryopreserved and readily 
differentiate into neurons and glial cells (Conti et al. 2005).
Two steps basically constitute the NSCs isolation protocol carried out in this 
project: (1) neural tissue dissociation and (2) positive selection of NSCs with anti- 
prominin-1 MicroBeads (MACS, Miltenyi Biotec) (Peh et al. 2009) (Figure 9). In the 
first step, after brain tissue micro-dissection the cortical hemispheres dissociation 
is achieved with an enzymatic degradation using papain, a protease able to breaks 
the extracellular adhesion proteins holding the cells together; in this way, the tissue 
can be dissociated to single-cell suspensions. Then, the second step leads to an 
enrichment of the cell population in NSCs. In order to do that, I incubated the cell 
suspension with anti-prominin-1 antibody. Prominin-1 is a transmembrane 
glycoprotein expressed in various stem cells, including those from postnatal CNS 
(Peh et al. 2009). Therefore, NSCs were magnetically labeled with anti-prominin-1 
MicroBeads and loaded onto a MACS® Column, which is placed in the magnetic 
field of a MACS Separator. The magnetically labeled prominin-1 + cells are retained 
within the column whereas the unlabeled cells run through. After removal of the
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column from the magnetic field, the magnetically retained prominin-1 + cells can be 
eluted as the positively selected cell fraction.
As reported in literature (Conti et al. 2005), in vitro NSCs grow in so-called 
neurospheres, floating heterogeneous aggregates of cells, containing a large 
proportion of stem cells. Isolated neurospheres were propagated in culture at 
clonal density on uncoated plates in medium containing EGF and FGF2 and with 
penicillin/streptomycin (NS expansion medium). Over 3-5 days, cells formed 
aggregates that, after harvesting and sedimentation to remove debris, 
subsequently outgrew NSCs.
From neurospheres, NSCs were conveniently dissociated to single cells and 
plated directly on coated plates, to finally obtain a monolayer cell culture. These 
cells were propagated in culture with NS expansion medium. The entire isolation 
protocol was carried out for three wild-type and three Sumfl -/- mice.
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Figure 9. NSCs isolation protocol
NSCs are isolated following a two step protocol: (1) brain tissue micro-dissection 
and neural tissue dissociation with papain, and (2) labeling of NSCs with magnetic 
anti-prominin-1 MicroBeads (MACS, Miltenyi Biotec) and positive selection 
through the magnetic field of a MACS Separator (MACS, Miltenyi Biotec).
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NSCs uniformly express morphological and molecular features of radial 
glia progenitors
Once established in culture, NSCs showed the typical elongated bipolar 
morphology with lamellate extensions, end-feet and oval nuclei anticipated for 
radial glia, with no substantial differences between MSD cells and their wild-type 
counterpart (Figure 10-A). In these conditions, NSCs proliferate continuously, with 
a doubling time of around 25 hours.
By flow cytometry analysis I observed that around 99.3% of the wild-type cells 
and 98.8% of MSD cells expressed the NSC marker nestin, suggesting that 
isolated NSCs have a defined progenitor identity (Figure 10-B).
Therefore, I analyzed their progenitor signature at a molecular level, testing a 
set of markers commonly used to define this cell population (Figure 11). By RT- 
PCR, I found that both wild-type and MSD-NSCs lacked the pluripotency marker 
genes typical of embryonic stem cells such as oct4 and nanog (Scholer et al. 1990; 
Cavaleri and Scholer 2003), whereas they expressed Pax6, and BLBP mRNAs 
(Hack et al. 2004; Feng, Hatten, and Heintz 1994, 199). In addition, NSCs 
expressed the neural precursor markers olig2, Sox2 and mashl (Gabay et al. 
2003; Lo et al. 1991) and lacked expression of dlx2, a marker of transient 
amplifying neuroblasts but not of NSCs (Fiona Doetsch et al. 2002) and, as 
expected, they did not express the marker of neuronal differentiation NF-L 
(Schimmelpfeng, Weibezahn, and Dertinger 2004). This set of markers is 
considered diagnostic for neurogenic radial glia, precursors of both neurons and 
astrocytes during development of the nervous system (Campbell and Gotz 2002;
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Hartfuss et al. 2001; Noctor et al. 2001).
Therefore, NSCs isolated from wild-type as well as those isolated from MSD 
affected littermates uniform ly express morphological and molecular features of 
radial glia progenitors.
A
W T MSD
Figure 10. NSCs exhibit morphologic similarities to radial glia
(A) Bright field pictures of isolated wild-type (WT) and MSD-NSCs showed 
elongated bipolar morphology with lamellate extensions, end-feet and oval nuclei 
anticipated for radial glia, and (B) Flow cytometry analysis revealed a high 
expression of the neurogenesis marker nestin in WT- (99.3 %) and MSD-NSCs 
(98.8 %).
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Figure 11. NSCs exhibit phenotypic similarities to radial glia
Expression pattern of a set of markers by RT-PCR on cDNA obtained by RNA 
retrotrnscription. RNA extraction was obtained from wild-type (WT) and MSD 
undifferentiated NSCs, from wild-type ESCs, and from wild-type mouse brain. Genes 
tested were divided in five different groups: stem cell markers (oct4, nanog), radial glia 
markers (pax6, bibp), pan-neuronal and region specific transcriptional regulators 
(sox2, olig2, mashi), a neuroblast marker (dlx2), and a differentiated neuron marker 
(NF-L).
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MSD-NSCs present a progressive loss of self-renewal
To assess whether in absence of SUMF1 protein NSCs display a defect in 
their ability to self-renew, I tested them with the neurosphere assay (Figure 12). 
Cells were plated as single cells at a density of 5x104 cells/ml in medium containing 
FGF2 and EGF. After incubation for 7 days, primary neurospheres were counted 
and then dissociated and re-plated in the same conditions; similarly, I generated 
secondary and tertiary neurospheres. I observed a significant decrease in the 
number of MSD tertiary neurospheres compared to wild-type counterpart, thus 
suggesting that accumulation of undegraded substrates is likely to impact on the 
ability of NSC population to self-renew. Interestingly, it was demonstrated that 
NSCs isolated from a mouse model of another neurodegenerative lysosomal 
disorder, Niemann-Pick disease type 1 (NPC1) show a similar defect in the self- 
renew (Yang et al. 2006); although a greater understanding of the machanisms 
involved in this defect is needed, this observation raises the possibility that 
neurodegeneration observed in LSDs may be characterized by a general reduction 
in the NSCs population, due to a defect in their self-renew ability.
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Figure 12. MSD neurospheres show an impaired seif-renewal
Bright field images of neurospheres assay. 5x1 ( f  cells/ml were plated in NS 
expansion medium and formed primary neurospheres (I); after 7 days primary 
neurospheres were counted and then dissociated and re-plated in the same 
conditions, generating secondary neurospheres (II); similarly, tertiary 
neurospheres (III) were generated. Scale bars represent 200 pM. Data are mean 
of replicates (n=30) ±  SEM; *p <  0.05 by Student’s t-test.
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MSD-NSCs are able to differentiate into astrocytes and neurons
Neural progenitors are committed cells with multipotential fate. To confirm the 
nature of isolated NSCs, I tested their ability to give rise to the two main cell types 
of the CNS: astrocytes and neurons. Thus, cell differentiation was studied at 
molecular level by immunofluorescence and immunoblotting using specific 
antibodies for differentiation markers, such as GFAP for glial differentiation, and 
Tuj1 for neuronal cells. Fully differentiation capacity was assessed by 
immunofluorescence looking at the absence of nestin expression after glial or 
neuronal differentiation protocols (Figure 13-A).
As expected, both wild-type and MSD-NSCs showed uniform expression of 
the progenitor marker protein nestin when kept in the undifferentiated state. 
Moreover, wild-type differentiated cells showed a uniform expression of GFAP or 
Tuj1, after glial or neuronal differentiation, respectively; at the same time, they did 
not show expression of nestin. In a similar way, MSD-NSCs were able to 
differentiate into glia and neurons, showing the same uniform expression of GFAP 
and Tuj1, respectively, and no expression of nestin. The same results were 
obtained by western blot analysis of protein homogenates from wild-type and MSD- 
NSCs, both undifferentiated and differentiated to glial and neural cells (Figure 13- 
B).
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Figure 13. MSD-NSCs correctly express differentiation markers
(A) Confocal microscopy image of wild-type (WT) and MSD undifferentiated NSCs 
(ND), glia (AG) and neurons stained with immunofluorescence detecting nestin 
(upper panel), GFAP (middle panel) and Tuj1 (lower panel). Scale bars represent 
50 pM. (B) Immunoblotting detecting GFAP (left panel) and Tuj1 (right panel) in 
protein extracts from NSCs, glia and neurons.
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MSD neurons develop neurites and are electrophysiologically active
During differentiation, neurons extend numerous processes that develop into 
dendrites and axons. These processes, also termed neurites, are critical for 
communication between neurons through interconnection of neuronal cell bodies. 
Moreover, neurite development was studied in another LSD, Sandhoff disease, 
which is a neurodegenerative disorder characterized by the deficiency in the 
hexosaminidase B (HEXB) gene; in particular in explant culture of retinal tissue 
from HexB -/- mice it was observed an impaired neurite outgrowth (Sango et al. 
2005), suggesting that lack of a lysosomal enzyme has an effect on neuronal 
branching. Therefore I performed the neurite assay in order to establish whether 
the absence of SUMF1 protein could affect neurite outgrowth of 3- and 7-days 
differentiating neurons (Figure 14-A). Nevertheless, I observed no differences in 
neurite outgrowth between MSD neurons and their wild-type counterpart, 
suggesting once again that neuronal differentiation and processes extension is not 
affected in MSD cells.
For unambiguous assignment of neuronal identity, we investigated the 
electrophysiological properties of neural differentiated NSCs. Toward this goal, in 
collaboration with Dr. Francesco Miceli and Prof. Maurizio Taglialatela from 
University of Naples “Federico II”, we recorded currents from wild-type and MSD- 
derived neurons using the whole-cell configuration of the patch-clamp technique. 
During depolarizing test potentials, MSD neurons and their wild-type counterpart, 
showed an inward current followed by a sizeable outward voltage-gated current, 
with features of a delayed-rectifier K+ current (Figure 14-B, upper panel).
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Furthermore, in MSD neurons the fast inactivating inward current was blocked by 
the selective Na+ channel blocker tetrodotoxin (TTX) (1 \iM) and peaked at a test 
potential of around -20 mV, typical features of voltage-gated Na+ currents in 
neurons (Figure 14-B, lower panel). These preliminary electrophysiological data 
suggest that isolated NSCs are capable to give rise to electrophysiologically active 
neurons, exhibiting excitability properties and underlying conductances typical of 
maturing nerve cells. Most importantly, we did not find any differences in the 
electrophysiological properties between MSD derived neurons and their wild-type 
counterpart.
Taken together, these observations suggest that MSD pathology does not 
affect the ability of NSCs to differentiate into astrocytes and functional neurons.
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Figure 14. MSD differentiated neurons develop proper neurites and are 
electrophysiologically active
(A) Neurite outgrowth assay and (B) electrophysiological test on NSC-derived 
neurons; superimposed inward and outward current tracings were obtained using the 
indicated electrophysiological protocol. Data are mean of replicates (n=2) ±  SEM.
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MSD-NSCs recapitulate the progressive GAG accumulation
MSD-affected mice present a massive accumulation of undegraded GAGs in 
brain tissue, vacuolization and increased neurodegeneration (Settembre et al.
2007). Thus, after the isolation and characterization of MSD NSCs, I started to 
study these pathologic features in differentiating cells. Firstly I observed that during 
both astrocyte and neuronal differentiation, MSD cells display a progressive and 
massive perinuclear vacuolization compared to their wild-type counterpart (Figure 
15-A). In particular, MSD cells display a thick cell body with enlarged extensions, 
whilst wild-type cells acquired the typical morphology of terminally differentiated 
CNS cells. In addition, MSD cells vacuoles have increasing dimensions during the 
course of the differentiation process, eventually reaching, and in some cases 
exceeding, the diameter of the nucleus. Electron microscopy analysis confirmed 
the presence of vacuole structures containing heterogeneous undegraded material 
(Figure 15-B).
Then I investigated whether MSD cells reflect also the main hallmark of the 
disease, which is the progressive accumulation of undegraded GAGs (Figure 16). 
By alcian blue staining (Figure 16-A) and GAG colorimetric assay (Figure 16-B) I 
detected increased levels of GAGs in MSD not-differentiated cells and in both glial 
and neuronal fate, reflecting the GAG storage phenotype observed in vivo. In fact, 
MSD-NSCs showed massive accumulation of GAGs even from the undifferentiated 
state; the storage then becomes prominent during both glial and neuronal 
differentiation and also increases as the differentiation proceeds, thus 
recapitulating the progressive accumulation seen in vivo. Pulse-and-chase
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experiments using H3-glucosamine to label GAGs confirmed that MSD 
differentiated cells accumulate GAGs (Figure 16-C).
The hypothesis is that during the differentiation process cells arrest their 
proliferation rate thus not dividing themselves anymore, and non-mitotic cells 
cannot dilute accumulating cytosolic content by cell division; in the case of MSD, 
due to the enzymatic inactivity of sulfatases, cells are not able to burn off the 
undegraded substrates that subsequently accumulate. In this condition, MSD cells 
accumulate all the undegraded material in a progressive manner as the 
differentiation proceeds.
Interestingly, also in a neuronal model of mucopolysaccharidosis type VII it 
was found a massive accumulation of abnormally high levels of GAGs, thus giving 
confidence to my model (Heuer et al. 2001).
These results suggest that long-term differentiated MSD-NSCs are able to 
recapitulate the main hallmarks of the disease, which is the progressive storage of 
GAGs.
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Figure 15. Differentiating MSD-NSCs display progressive vacuolization and 
undegraded material
(A) Bright field images of wild-type (WT) and MSD-NSCs, glia and neurons. (B) 
Electron Microscopy images of WT and MSD-derived glia cells. Scale bars represent 
50 pM (A) and 1 pM (B).
71
A
N D  glia neurons
B glia
2 .5
2
,5
1
.5
0
ND 1 day 2 days
■ W T
M SD
neurons
5 days 7 days 9 days
'W T
M S D
® 600
co 200
Figure 16. Differentiated MSD-NSCs display progressive accumulation of GAGs
(A) Alcian-blu staining of GAGs on wild-type (WT) and MSD-NSCs, glia and neurons. 
Scale bars represent 50 pM. (B) GAG quantitative assay on wild-type and MSD- 
NSCs, glia (left panel) and neurons (right panel). (C) Pulse-and-chase incorporation of 
H3-glucosamine in wild-type and MSD-derived glia cells. Data are mean o f replicates 
(n=5) ± SEM; *p < 0.05 by Student’s t-test (B and C).
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MSD differentiated cells suffer from impaired autophagy
In a previous work from our laboratory, it was shown that LSDs are 
associated with a lysosomal dysfunction that impairs the autophagic pathway 
(Settembre et al. 2008). This impairment ultimately leads to cell death, although the 
detailed mechanism has not been described yet. In particular, it was demonstrated 
that in MSD pathology a block of autophagic pathway occurs as a consequence of 
decreased ability of lysosomes to fuse with autophagosomes. Accordingly to this 
previous in vivo data, I observed an increase of LC3-II levels in cellular extracts 
from glial and neuronal differentiated MSD-NSCs (Figure 17-A), thus indicating 
autophagic activation. However, the autophagy process requires the fusion of 
newly formed autophagosomes with lysosomes, in order to digest autophagosome 
content; in glia differentiated MSD-NSCs I observed a decreased intracellular co­
localization of autophagosome punctae containing LC3-II molecules with the 
lysosomal membrane protein marker cathepsin D (CatD) (Figure 17-B), suggesting 
an impaired fusion of autophagosomes with lysosomes and a block of the 
autophagy process.
The consequential effect of defective autophagy is the accumulation of poly- 
ubiquitinated proteins normally destined for recycling in the lysosomal 
compartment; in fact, poli-ubiquitin is a well-known signal for protein degradation. 
As expected, I detected a massive accumulation of poly-ubiquitinated proteins in 
MSD not differentiated cells, but also in glia and neurons, by immunofluorescence 
(Figure 18-A, left panel) and immunoblotting (Figure 18-B, left panel). These results 
confirm those found in the previous in vivo work (Settembre et al. 2008), in which a
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massive and progressive accumulation of ubiquitin-positive inclusions were 
observed in the cerebral cortex as well as in other brain regions of MSD mice.
In addition, I found that p62/SQSTM1, a protein involved in targeting poly- 
ubiquitinated proteins to the autophagosomes (Pankiv et al. 2007), significantly 
accumulates in differentiated MSD-NSCs, both glia and neurons (Figure 18-A and 
B, right panels). The p62/SQSTM1 protein is known to be a common component of 
ubiquitin-positive protein aggregates in neurodegenerative diseases, being 
involved in targeting poly-ubiquitinated proteins to the autophagosomes, where 
they are selectively degraded via the autophagic pathway.
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Figure 17. Differentiating MSD-NSCs display impaired autophagy
(A) Immunoblotting of LC3-I and - I I  in wild-type (WT) and MSD undifferentiated cells 
(ND), glia and neurons (left panel). LC3-ll/Bact ratio (right panel). (B) Confocal 
microscopy image of immunofluorescence detecting LC3 and CatD in WT and MSD- 
NSCs, undifferentiated and differentiated to glia. Scale bars represent 10 pM. Arrows 
indicate colocalization between autophagosomes (marked with LC3) and lysosomes 
(marked with CatD), suggesting that in glia-differentiated WT cells autophagosomes 
properly fuse with lysosomes and, therefore, the autophagy process is working. Such 
colocalization is not present in glia-differentiated MSD cells, suggesting a block of the 
autophagy process.
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Figure 18. Differentiating MSD-NSCs display accumulation of poly-ubiquitinated 
proteins and p62/SQSTM1
(A) Epifluorescence microscopy image of immunofluorescence detecting poly-ubiquitin (left 
panel) and p62/SQSTM1 (right panel) in wild-type (WT) and MSD undifferentiated cells 
(ND), glia and neurons. Scale bars represent 10 pM. (B) Immunoblotting of poly-ubiquitin 
and p62/SQSTM1 in WT and MSD ND cells, glia and neurons.
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MSD differentiated cells display the tendency to form aggresomes
It has been demonstrated that when poly-ubiquitinated misfolded proteins 
cannot be properly cleared, they accumulate into the aggresome (Goldberg 2003; 
Kawaguchi et al. 2003), an inclusion body localized in the proximity of the 
microtubule-organizing centre (MTOC) (Iwata et al. 2005; Pandey et al. 2007), 
where protein aggregates are ensheathed by the intermediate filament protein 
vimentin (Johnston, Ward, and Kopito 1998). Microtubule-associated histone 
deacetylase 6 (HDAC6) mediates this process (Matthias, Yoshida, and Khochbin
2008) through its ubiquitin-binding domain (UBA): HDAC6 binds to and facilitates 
the transport of poly-ubiquitinated misfolded proteins along microtubules to 
aggresome (Kawaguchi et al. 2003).
In wild type NSCs differentiated to glia we observed a typical cytoscheleton- 
associated localization of HDAC6, while in glia-differentiated MSD-NSCs we found 
an increase in the amount of HDAC6 detected by immunoblotting analysis (Figure 
19-A, left panel), as well as an altered punctate cytoplasmic staining, occasionally 
colocalizing with poly-ubiquitinated proteins, as shown by immunofluorescence on 
wild-type and MSD glia cells (Figure 19-B, upper panel). Immunoblotting analysis 
showed also a consistent increase in vimentin expression (Figure 19-A, right 
panel). These observations suggest that, as a consequence of impaired 
autophagy, the presence of poly-ubiquitinated proteins produce an elevation in the 
levels of HDAC6, whose role is to target them to the aggresome.
Aggresome clearance is then mediated by ubiquitin-binding proteins like 
p62/SQSTM1 and neighbor of BRCA1 gene 1 (NBR1) (Kirkin et al. 2009), and in
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fact we observed a higher co-localization of p62/SQSTM1 and HDAC6 in glia 
differentiated MSD-NSCs compared to wild type cells (Figure 19-B, lower panel), 
suggesting an increased aggresome formation. As an adaptor protein, 
p62/SQSTM1 is then responsible for misfolded protein degradation through 
autophagy pathway (Kirkin et al. 2009; Komatsu et al. 2010; Komatsu et al. 2007), 
which is impaired in MSD pathology. In fact, we did not observed co-localization 
between poly-ubiquitinated protein aggregates and the autophagy marker LC3, 
suggesting that the block of the autophagy process observed in vivo impairs not 
only the fusion of lysosomes with autophagosomes, but also the sequestration of 
toxic protein aggregates within the cytoplasm. In fact, even when we induced 
autophagy activation through starvation of undifferentiated cells we still did not 
observe the incorporation of poly-ubiquitinated proteins inside autphagosomes, 
rather producing as the only effect an increase in the size of aggregates (Figure 
20).
As far as we known this is the first time that aggresome has been described 
in brain-derived cells from mice affected of MSD. Therefore, more experiments are 
needed to assess the contribution of aggresome formation in MSD pathology, and 
in particular its role in neurodegeneration.
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Figure 19. Differentiating MSD-NSCs display the tendency to form aggresomes
(A) Immunoblotting of HDAC6 and vimentin in wild-type (WT) and MSD-glia. (B) 
Epifluorescence microscopy image of immunofluorescence detecting poly-ubiquitin (upper 
panel) and p62/SQSTM (lower panel) in WT and MSD cells, glia and neurons. Scale bars 
represent 10 pM.
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Figure 20. Defects in the autophagy pathway impairs toxic protein aggregates 
sequestration into autophagosomes.
Epifluorescence microscopy image of immunofluorescence detecting poly-ubiquitin and 
LC3 in wild-type (WT) and MSD undifferentiated cells (ND). Scale bars represent 10 pM. 
Incorporation of poly-ubiquitinated proteins inside autphagosomes in MSD ND cells was 
not observed upon starvation-induced autophagy.
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MSD differentiated cells show increased apoptosis
To determine whether the accumulation of GAGs, poly-ubiquitinated proteins, 
p62/SQSTM1 and the block of autophagy are likely to sensitize NSCs to cell death, 
I analyzed the levels of apoptosis in MSD-NSCs (Figure 21). I tested their viability 
in the undifferentiated state and also in the two main differentiation programs, glia 
and neurons. Apoptosis was measured by TUNEL (Terminal deoxynucleotidyl 
transferase dUTP nick end labeling) assay, a method for detecting DNA 
fragmentation resulting from apoptotic signaling cascades, by labeling the terminal 
end of nucleic acids. I observed that in undifferentiated conditions or during the 
differentiation programs MSD cells suffer an increased level of apoptosis. These 
findings well correlated with previous in vivo data, showing elevated apoptosis in 
brain cortex of MSD mice. These results suggest that brain progenitor cells from 
MSD brain are sensitized to apoptosis and, together with the reduced self-renew 
ability, this might count for the reduced brain size observed in early MSD pups 
(Settembre et al. 2007). In addition, after differentiation the cells are even more 
sensitized to apoptosis in vitro suggesting that the progression of lysosomal 
accumulation is even deleterious for post-mitotic NSCs.
In summary, MSD-NSCs represent a confident model to recapitulate in vitro the 
basic features of the disease, and that represent a useful tool to investigate the 
mechanisms of neurodegeneration.
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Figure 21. MSD-NSCs suffer increased apoptosis
Tunel assay was performed following the manufacturer’s manual (Roche) on NSCs, glia 
and neurons derived from wild-type (WT) and MSD cells. Data are mean of replicates 
(n=20) ±  SEM; *p <  0.05, **p <  0.005, *p <  0.0005 by Student’s t-test.
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TFEB induces lysosomal biogenesis in NSCs
Lysosomal biogenesis and function are transcriptionally regulated by TFEB 
(Sardiello et al. 2009). Moreover, TFEB overexpression not only increases the 
number of lysosomes in the cell, but it is also able to improve the degradative 
capability of the cell, as showed by the reduction of accumulated expanded 
huntingtin in a neuronal cell model of HD (Sardiello et al. 2009).
Therefore we questioned whether TFEB could mediate the clearance of 
accumulated material also in a cellular model of LSD. In particular, we investigated 
whether TFEB overexpression could reduce GAG accumulation in MSD-NSCs.
Firstly we observed that TFEB overexpression in NSCs increased lysosomal 
compartment (Figure 22). We nucleofected wild-type and MSD-NSCs with a 
bicystronic plasmid expressing TFEB-GFP and performed an immuno-fluorescence 
against LAMP1, a lysosomal membrane protein, in order to visualize the lysosomal 
compartment. Cells overexpressing TFEB always showed an increased LAMP1 
compared to non-transfected cells in their proximity, with a slightly enhanced signal 
in MSD cells.
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Figure 22. TFEB overexpression increases lysosomal compartment in NSCs
Epifluorescence microscopy image of immunofluorescence of LAMP 1 in NSCs transfected 
with a bicystronic plasmid expressing TFEB-GFP. Cells expressing TFEB were localized 
by the expression of GFP; non-transfected cells are indicated by asterisks. Scale bars 
represent 10 pM.
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TFEB promotes cellular clearance in MSD-NSCs
We tested whether TFEB-mediated increase of the lysosomal compartment 
could be exploited to induce cellular clearance in MSD-NSCs (Medina et al. 2011). 
Specifically, we evaluated the effect of TFEB overexpression on the clearance of 
GAGs in glia differentiated MSD-NSCs (Figure 23); we nucleofected cells with 
either a TFEB plasmid or with an empty plasmid and after 24 hours we induced glia 
differentiation for 48 hours; at the end of the differentiation program, we performed 
the alcian blue staining to reveal the amount of GAG accumulation within cells. 
Interestingly, TFEB overexpression resulted in a striking reduction of alcian blue 
stained GAGs in MSD glial cells (Figure 23-A), suggesting that TFEB is able to 
modulate cellular clearance also in cells affected by a lysosomal storage disorder.
This result was further confirmed by pulse-and-chase experiments using H3- 
glucosamine to label GAGs (Figure 23-B). Wild-type and MSD-NSCs were 
nucleofected either with a TFEB plasmid or with an empty plasmid, and after 16 
hours, cells were pulsed with H3-glucosamine in differentiation medium and chased 
for 48 hours. Cell extracts obtained were quantified to determine the levels of 
labeled GAGs. The experiment showed a significant reduction of the levels of 
labeled GAGs in MSD glial cells overexpressing TFEB.
Finally, EM analysis revealed that TFEB-mediated clearance of GAGs in 
TFEB-overexpressing MSD cells was associated with both significant reduction of 
cellular vacuolization and recovery of normal intracellular morphology (Figure 23- 
C). Glia-differentiated MSD-NSCs were nucleofected with either TFEB or with an 
empty vector, fixed with glutaraldehyde and processed for standard electron
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microscopy. The number of vacuoles per cell was significantly reduced in cells 
overexpressing TFEB compared to the empty vector, thus confirming the clearing 
potential of TFEB on pathologic vacuolization, typical of LSD cells and tissues.
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Figure 23. TFEB promotes cellular clearance in MSD-NSCs
(A) Alcian-blu staining o f GAGs of MSD-derived glia cells nucleofected with either an 
empty vector or TFEB plasmid. (B) Pulse-and-chase incorporation o f H3-glucosamine of 
wild-type and MSD-derived glia cells nucleofected with either an empty vector or a TFEB 
plasmid. (C) Electron Microscopy of MSD-derived glia cells nucleofected with either an 
empty vector or TFEB plasmid. Scale bars represent 100 pM (A) and 10 pM (B). Data are 
mean of replicates (n=3) ± SEM; *p < 0.05 by Student’s t-test (B and C)
4C DO
3000
2000
87
TFEB Overexpression Induces Lysosomal Exocytosis
Since TFEB is not able to replace the missing SUMF1 gene product in MSD 
NSCs, we postulated that the overexpression of TFEB may be able to induce the 
activation of lysosomal exocytosis, a secretory pathway that allows lysosomes to 
empty their content in the extracellular space. As we know, lysosomal exocytosis 
requires two sequential steps; in the first step lysosomes are recruited to the close 
proximity of the cell surface in a Ca2+-independent manner (Jaiswal, Andrews, and 
Simon 2002), and in the second step the pool of predocked lysosomes fuse with 
the PM in a Ca2+-dependent manner, thus emptying their content outside the cell 
(N W Andrews 2000; Jaiswal, Andrews, and Simon 2002; Tucker, Weber, and 
Chapman 2004).
Hence, a typical hallmark of lysosomal exocytosis is the translocation of 
lysosomal membrane markers to the PM (Reddy, Caler, and Andrews 2001; 
Rodriguez et al. 1997; Yogalingam et al. 2008). Therefore we detected LAMP1, a 
lysosomal membrane marker, using an antibody against its luminal portion, and in 
conditions of non-permeabilized wild-type NSCs, transfected with either a 
bicystronic plasmid expressing TFEB-GFP or an empty vector. Interestingly, TFEB 
overexpression resulted in an increased exposure of the luminal domain of LAMP1 
on the PM, thus suggesting an increased translocation of lysosomes to the PM 
(Figure 24-A).
Consistently, also a quantitative analysis by flow cytometry (FACs) showed 
an increase of LAMP1 staining on the PM of TFEB-overexpressing wild-type NSCs 
(Figure 24-B).
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Furthermore, a direct consequence of lysosomal exocytosis is the release of 
lysosomal enzymes into the cell culture medium (Rodriguez et al. 1997). Therefore 
we analyzed the presence of acid hydrolases in the culture medium of wild-type 
NSCs transfected with either a bicystronic plasmid expressing TFEB or an empty 
vector (Figure 24-C). Significantly higher levels of lysosomal hydrolases were 
detected in the medium of NSCs overexpressing TFEB compared with control 
cells. However, the increase of lysosomal enzymes in the medium was not 
associated with an increase in the levels of cytosolic lactate dehydrogenase (LDH) 
(Figure 24-D), thus excluding that the release of lysosomal enzymes was due to 
cell damage and that TFEB overexpression is cytotoxic. Together, these data 
indicate that TFEB induces lysosomal exocytosis (Medina et al. 2011).
89
•o 35
cd
1  30
CD
S '25
I  20o
CO
CD 15 
E >»
N  
C
5  5
10
caacid phosphatase 
m  8-galactosidase 
■■ 8-nexosaminidase
III
. m . m  CD 
? r lU r r  UJ r rU J  
t Z U L t Z  I L u l L
o ^ o ^ o * "T + + -fc
NSCs
0  >  0.3
q.E 0.2
CTRL TFEB
WT NSCs
Figure 24. TFEB Overexpression Induces Lysosomal Exocytosis
(A) Con focal microscopy image of immunofluorescence detecting the luminal portion of 
LAMP1 (with the antibody LAMP1-1DB4) in non-permeabilized wild type NSCs transfected 
with either a bicystronic plasmid expressing TFEB-GFP or with an empty vector. TFEB- 
transfected cells were localized by the expression of GFP; non-transfected cells are 
indicated by asterisks. (B) Quantitative analysis by flow cytometry of LAMP1 levels on the 
PM in wild-type NSCs that express either a bicystronic TFEB-GFP plasmid or GFP. Bars 
represent the fold increase of LAMP1 fluorescence in TFEB-transfected versus GFP- 
transfected (CTRL) cells. (C) Activities of lysosomal enzymes acid phosphatase, b- 
galactosidase, and b-hexosaminidase in the culture medium of wild-type NSCs 
nucleofected with either an empty vector or with a TFEB-expression vector. The figure 
shows percentages of enzyme activities released compared with total activities. (D) LDH 
activity was determined following the manufacturer’s manual (Abeam) in supernatants of 
NSCs transfected either with TFEB or with an empty vector. Data are mean of replicates 
(n=4) ±  SEM (B, C and D). *p <  0.05 by Student’s t-test (B and C)
TFEB Overexpression Enhances Lysosomal Predocking to the PM and 
Elevates Intracellular Ca2+
Induction of lysosomal exocytosis involves the recruitment of lysosomes to 
the PM (Blott and Griffiths 2002). To clearly demonstrate that TFEB overexpression 
resulted in an increased motility of lysosomes we took advantage of a HeLa cell 
line stably expressing TFEB (HeLa CF7) using the immuno-EM approach (Figure 
25-A). In HeLa control cells lysosomes were distributed randomly throughout the 
cells, whilst CF7 cells exhibited numerous lysosomes in the close proximity of the 
PM, indicating that TFEB overexpression significantly stimulates the recruitment of 
lysosomes to the PM, a step that is required for lysosomal exocytosis.
Several studies demonstrated that the elevation of Ca2+ concentrations is 
required for the fusion of lysosomes with the PM, but not for the previous step of 
the recruitment of lysosomes to the cell surface (N W Andrews 2000; Jaiswal, 
Andrews, and Simon 2002; Rodriguez et al. 1997). We also demonstrated that in 
HeLa control cells the overexpression of TFEB led to an elevation of intracellular 
Ca2+ levels (Figure 25-B), consistent with the role of TFEB in the induction of 
lysosomal exocytosis.
To assess whether the elevation of intracellular Ca2+ levels was responsible 
for the activation of lysosomal exocytosis and thus for the clearance of 
accumulated GAGs, we tested TFEB ability to reduce storage in presence of a 
Ca2+ inhibitor (Figure 25-C). Therefore, we nucleofected MSD-NSCs with a TFEB 
plasmid, we differentiated them to glia and at the same time we treated them with 
the Ca2+ chelator, BAPTA-AM, at increasing concentrations; then, after 48 hours,
91
alcian blue staining of GAGs was performed. We observed an inhibition of GAG 
clearance after the addition of BAPTA to TFEB overexpressing NSCs, confirming 
the involvement of Ca2+ in TFEB-mediated reduction of pathologic storage.
Together, these results indicate that in addition to promoting lysosomal 
recruitment to the PM, TFEB induces lysosomal exocytosis by enhancing Ca2+- 
mediated fusion of lysosomes with the PM (Medina et al. 2011).
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Figure 25. TFEB enhances PM proximity of lysosomes and Intracellular Ca2+ Release
(A) Immuno-Electron Microscopy in control and HeLa CF7. Cells were fixed and labeled 
with the antibodiy against LAMP1 and prepared for immuno-EM. LAMP1 detected at a 
substantial distance from the cell surface are indicated by arrows, while lysosomes that are 
close to the PM are indicated by arrowheads. The distance between lysosomes and PM 
was estimated in thin sections and 100 lysosomes were counted for each condition. Scale 
bars represent 350 nm. (B) Analysis of intracellular Ca2+ by confocal microscopy of HeLa 
cells transfected with a bicystronic TFEB-GFP construct. Data are displayed as the 
percentage of cells with Ca2+ response compared with the non-transfected cells. (C) Ca2+ 
involvement in TFEB-mediated GAG clearance in MSD-NSCs. Alcian blue staining of 
GAGs was performed on glia-differentiated MSD-NSCs nucleofected with a TFEB. The 
cells were treated with different concentrations of the Ca2+ chelator BAPTA-AM for 12 
hours.
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TFEB Releases Ca2+ from Acidic Stores through the Activation of 
Mucolipin-1
Although we demonstrated that TFEB overexpression strongly activates 
lysosomal exocytosis and eventually leads to the clearance of pathologic material, 
the mechanism of action was still left to clarify.
In a separate study, we demonstrated that among other genes belonging to 
the network, TFEB regulates the expression of the gene encoding MCOLN1 
(Palmieri et al. 2011), a lysosomal non-selective cation channel that is mutated in 
MLIV, a severe type of LSD (Bargal et al. 2000; Bargal et al. 2002; Bassi et al. 
2000). Previous studies reported that lysosomal exocytosis is reduced in MLIV 
cells (LaPlante et al. 2006) and increased in cells expressing gain-of-function 
MCOLN1 mutations (X. Dong et al. 2009). These observations made MCOLN1 an 
appealing candidate to mediate TFEB effects on lysosomal exocytosis, suggesting 
that MCOLN1, upon a proper cellular stimulation, mediates intralysosomal Ca2+ 
release to trigger lysosomal exocytosis.
Therefore, we performed a flow-cytometry Ca2+ flux assay in NSCs 
transfected with a control vector, a vector containing a scramble shRNA plus TFEB 
plasmid, and a vector containing a pool of four fluorescently tagged vectors 
carrying specific MCOLNI-shRNAs plus TFEB plasmid (Figure 26-A). Levels of 
Ca2+ were determined in resting condition and after stimulation with ionomycin (10 
micromolar), an ionophore that raises the intracellular level of Ca2+. Remarkably, 
TFEB-mediated increase of intracellular Ca2+ was blocked in NSCs overexpressing 
TFEB by transient silencing of MCOLN1 with shRNAs, suggesting a crucial role of
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MC0LN1 in TFEB-mediated activation of lysosomal exocytosis. This observation 
was further confirmed also in HeLa cells stably depleted for MCOLN1 (HeLa 
shMCOLNI) (Figure 26-B) and in human MLIV fibroblasts (Figure 26-C). In 
addition, stable depletion of MCOLN1 in HeLa cells also impaired TFEB-mediated 
fusion of LAMP1 with the PM (Figure 26-D) and secretion of lysosomal enzymes 
(Figure 26-E).
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Figure 26. TFEB elevates intracellular Ca2+ levels through the activation of MCOLN1
(A) Flow-cytometry Ca + flux assay in NSCs transfected with a control vector, a vector 
containing a scramble shRNA plus TFEB plasmid, and a vector containing a specific 
shRNA against MCOLN1 plus TFEB plasmid. Ca2+ was determined in resting condition 
and after stimulation with ionomycin (10 pM). (B and C) Analyses of intracellular Ca2+ by 
confocal microscopy of (B) HeLashMCOiN and (C) human MLIV fibroblasts transfected with a 
bicystronic TFEB-GFP construct. Data are displayed as the percentage of cells with Ca2+ 
response compared with non-transfected cells. (D) Flow-cytometry analysis o f LAMP1 on 
the PM of HeLashMCOiN1 cells transfected with TFEB. (E) Secretion o f lysosomal b- 
galactosidase in HeLashMCOiN1 cells. Secretion efficiency was calculated as the % of 
enzymatic activity in the medium with respect to the total activity (medium and cellular 
pellet). Data represent mean of replicates (n=5) ± SEM; *p < 0.05 (A-E). Scale bars 
represent 10 mm (B) and 25 mm (C).
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Furthermore, the lysosomal localization of MCOLN1 and its channel 
properties suggested that the elevation of intracellular Ca2+ levels induced by TFEB 
overexpression was due to the release of Ca2+ from lysosomal stores through 
MCOLN1. In fact, we treated cells with the inhibitor of the v-ATPase, Bafilomycin 
A1, which is responsible for the proton gradient driving lysosomal Ca2+ uptake 
(Christensen, Myers, and Swanson 2002), and therefore induces acidic Ca2+ 
release. The result clearly showed that both TFEB and MCOLN1 overexpressing 
HeLa cells were less sensitive to Bafilomycin A1-dependent depletion of lysosomal 
Ca2+ compared to HeLa control cells (Figure 27-A). This suggests that in a 
condition of induced lysosomal exocytosis, acidic stores of Ca2+ are actively being 
used to induce the fusion of lysosomes with PM and Bafilomycin A1 effect is less 
prominent if compared to control cells.
Moreover, we tested TFEB-mediated clearance of accumulated material in 
human MLIV fibroblast; cells were transfected with either TFEB-FLAG or with an 
empty vector and analyzed by confocal microscopy. TFEB overexpression did not 
reduce lipofuscin accumulation in human MLIV fibroblasts (Figure 27-B), thus 
confirming the importance of MCOLN1 function in TFEB-mediated clearance of 
lysosomal storage.
Together these data strongly suggest that MCOLN1-dependent release of 
Ca2+ from acidic Ca2+ stores plays a major role in TFEB-mediated lysosomal 
exocytosis (Medina et al. 2011).
At this point, we questioned whether MCOLN1 overexpression could mediate 
activation of lysosomal exocytosis, with no participation of TFEB. Thus, to assess 
whether MCOLN1 on its own was able to reduce GAG accumulation as well as
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TFEB, we performed Alcian blu staining on glia-differentiated MSD-NSCs infected 
with either a lentiviral vector carrying TFEB or an adenoviral vector encoding 
MCOLN1. We observed reduced GAG accumulation in cells overexpressing 
MCOLN1, but to a lesser extent compared with TFEB, suggesting that Ca2+ 
elevation is required but not sufficient to mediate TFEB effects on lysosomal 
exocytosis. In fact, MCOLN1 overexpression only partially reduced GAG pathologic 
storage.
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Figure 27. MC0LN1 plays a central role in TFEB-mediated activation of lysosomal 
exocytosis
(A) Ca2+ levels were measured by loading cells with the ratiometric fluorescent dye 
FuraRed. After 1.5 min of confocal time-lapse acquisition, cells were treated with 1uM 
Bafilomycin A1 to induce the release of Ca2+ from the acidic compartment. Data represent 
the F458/F488 ratio of each experimental group compared with their basal ratio before 
stimulation (F/F0*100). (B) Human MLIV disease fibroblasts were transfected with either 
TFEB-FLAG or with an empty vector and analyzed by confocal microscopy. (C) Alcian blue 
staining of GAGs in glia-differentiated MSD-NSCs infected with either a lentiviral vector 
carrying TFEB or an adenoviral vector encoding MCOLN1.
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To further confirm that the clearance is effectively mediated by exocytosis, we 
measured the secretion efficiency of GAGs in the culture medium of MSD-NSCs 
overexpressing TFEB (Figure 28-A). Cells were nucleofected with either TFEB or 
an empty vector after pulse-chase incorporation of H3-glucosamine and then 
radioactive GAGs were measured in the culture medium. When MSD-NSCs were 
overexpressing TFEB, we observed an increase in GAG secretion in the cell 
culture medium, thus confirming that clearance is mediated by exocytosis.
We then extended these studies to other types of LSDs associated with the 
storage of different types of lysosomal substrates, like Neuronal Ceroid 
Lipofuscinosis type 3 (CLN3 or Batten disease), and glycogenosis type II (or 
Pompe disease), characterized by the accumulation of lipofuscin and glycogen, 
respectively (Beratis, LaBadie, and Hirschhorn 1978; Persaud-Sawin et al. 2007). 
We found that TFEB overexpression strongly reduced lipofuscin autofluorescence 
in cells from a murine model of NCL3, and also in fibroblasts from a patient 
affected by glycogenosis type II, Pompe disease (Figure 28-B). These data indicate 
that induction of lysosomal exocytosis promotes cellular clearance in diseases due 
to accumulation of different types of lysosomal substrates. Notably, all diseases 
tested (i.e., MSD, Batten, and NCL) are due to deficiency of proteins whose activity 
is involved in crucial steps of different catabolic pathways. In addition, the cells 
analyzed were derived from patients and murine models carrying either null 
mutations or mutations that severely inactivate protein function. Therefore, it is 
unlikely that clearance of lysosomal substrates is due to either the enhancement of 
the activity of the defective enzymes, or to an overall induction of lysosomal 
catabolic processes, suggesting that clearance is mediated by exocytosis.
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Figure 28. TFEB clearance is mediated by exocytosis and is tested in Batten and 
Pompe diseases’ cellular model.
(A) Secretion efficiency of radioactive GAGs measured in the culture medium of MSD- 
NSCs nucleofected with either TFEB or an empty vector after pulse-chase incorporation of 
H3-glucosamine. Data represent mean ±  SEM; *p <  0.05 (B and C). (B) TFEB promotes 
clearance of lipofuscin in fibroblasts from a patient with Batten disease (upper panel) and 
of the fluorescent sugar 2-NBDG in human Pompe disease fibroblasts (lower panel). Cells 
were transfected with a vector carrying TFEB-Ruby (continuous red staining). After 24 hr, 
cells were examined by live imaging confocal analysis. Cells with increased TFEB (i.e., 
cells with red signal in the picture and outlined by dashed white lines in the middle panel) 
display highly reduced levels of lipofuscin or 2-NBDG (punctate green signal) and a normal 
cellular morphology compared with non-transfected cells (i.e., cells with intense green 
staining).
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TFEB induces storage clearance in a mouse model of MSD
Finally, we tested whether in vivo overexpression of TFEB in the mouse 
model of MSD had similar effects on cellular clearance (Figure 29). To this end, we 
injected systemically into adult MSD mice an adeno-associated virus type 2/9 
(AAV2/9) that carries TFEB-3xflag or GFP, both under control of the 
cytomegalovirus (CMV) promoter. One month after injection, several tissues were 
collected to monitor transduction efficiency and GAG storage; AAV-mediated TFEB 
delivery was detected using a specific anti-flag antibody and resulted in efficient 
TFEB transduction (Figure 29-A, left panel). In both liver and skeletal muscles we 
observed a significant reduction of GAG amount, as detected by alcian blue 
staining and GAG quantification (Figure 29-A, right panel, and B).
Subsequently, we investigated whether TFEB-mediated clearance of GAGs 
resulted in the reduction of the pathologic hallmarks of MSD, such as macrophage 
infiltration and apoptosis (Settembre et al. 2007) (Figure 30). We found a striking 
reduction of CD68-positive cells in the liver of AAV-TFEB injected MSD mice 
compared with MSD non-injected littermates (Figure 30-A). Most importantly, we 
also observed a significant reduction of apoptotic cells in liver of 4-month-old MSD 
mice injected with an AAV2/9-CMV-TFEB3xflag viral vector (Figure 30-B); we 
counted the number of TUNEL-positive cells and compared it with age matched 
MSD non-injected mice.
These results indicate that TFEB activation of lysosomal exocytosis reduces 
both primary accumulation of GAGs and secondary pathological processes 
associated with LSDs, such as inflammation and cell death (Medina et al. 2011).
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Figure 29. TFEB overexpression reduces GAG storage in a mouse model of MSD
(A) Representative immunofluorescence of liver and muscle sections infected with AAV- 
TFEB-FLAG (left panel) and alcian blue staining of GAG content in skeletal muscle and 
liver from mice injected systemically with either an AAV2/9-CMV-GFP or with an AAV2/9- 
CMV-TFEB3xflag viral vector (right panel). (B) Quantitative analysis of GAG content in liver 
(left panel) and skeletal muscle (right panel) of MSD mice injected with either an AAV2/9- 
CMV-GFP or with an AAV2/9-CMVTFEB3xflag viral vector. GAG content was displayed as 
mg of GAGs/mg of tissue extract. At least four mice per group were analyzed for each 
tissue examined (*p < 0.05). Data are mean of replicates (n=5) ± SEM; *p < 0.05.
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Figure 30. TFEB overexpression reduces tissue pathology in a mouse model of MSD
(A) TFEB reduces inflammation in the liver of MSD mice. Macrophages and macrophage- 
related inflammatory cells were detected in liver sections from mice injected systemically 
with either an AAV2/9-CMV-GFP or with an AAV2/9-CMV-TFEB3xflag viral vector by 
immunofluorescence analysis using an antibody against CD68. (B) Reduction of TUNEL- 
positive cells (arrows) in 4-month-old MSD mice injected with an AAV2/9-CMV-TFEB3xflag 
viral vector compared with age-matched MSD non-injected mice. At least four mice per 
group were analyzed for each tissue examined). Data are mean of replicates (n=5) ±  SEM; 
*p <  0.05 (B and D). Scale bars represent 100 mm (A, C, and D).
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DISCUSSION
NSCs recapitulate the main hallmarks of MSD pathology
Most of the LSDs present neurological involvement, but yet little is known 
about the mechanism of neurodegeneration. Intracellular accumulation of 
undegraded compounds are the primary effect observed in patients as well as in 
animal models, but whether they are the direct cause of cell death it is not clear; 
most likely the primary accumulation of undegraded substrates triggers secondary 
pathologic cascades, such as impaired autophagy, which in turn contributes 
together with global lysosomal dycfunction to neurodegeneration.
Post-mitotic neurons do not replicate in adult life and have a highly developed 
lysosomal network for membrane recycling: lysosomes are trafficked in axonal 
fibres using molecular motors to ensure that, as the cytoplasm extends to the far 
reaches and ramifications of the axon, distribution of the organelle is maintained 
(Tsukita and Ishikawa 1980). For this reason, the well-being of the lysosomal 
compartment has a particularly high relevance in post-mitotic neurons, and any 
perturbation of its proper function can cause neurological deficits, with or without 
cell death. In fact, in lysosomal diseases, electron microscopy of neurons, as well 
as other cell types, shows formation of vacuoles and lysosomes distended by 
recognizable cellular cargo (Walkley et al. 2010). Thus, it does not surprise that 
two-thirds of lysosomal diseases have potentially devastating consequences in the 
nervous system, and therefore future therapeutic research will require an
105
integrative understanding of the unitary steps in their neuronal pathogenesis.
Multiple Sulfatase Deficiency is a neurodegenerative lysosomal disease 
caused by the deficiency of a non-lysosomal protein; in fact, SUMF1 resides in the 
ER, where it is responsible for the post-translational activation of a whole family of 
enzymes, sulfatases. Patients suffering from MSD combine clinical symptoms of 
the different single sulfatase defects, with a severe impairment of neurological 
abilities. Sumfl -/- mice recapitulate all the features of the disease observed in 
MSD patients, obviously including neurodegenerative aspects. The Sumfl -/- 
mouse model not only allows a systematic study of the pathophysiology of MSD; 
importantly, it also provides a model to test therapeutic approaches to the 
treatment of MSD, similar to other mouse models of individual LSDs.
These observations prompted us to develop a reliable system to generate a 
neural cellular model from MSD mice, in order to investigate the signaling 
pathways involved in the neuronal pathology and eventually develop novel 
therapeutic strategies.
Furthermore, MSD mice are asymptomatic immediately after birth, but soon 
after they display congenital growth retardation and frequent mortality in the first 
weeks of life (Settembre et al. 2007). This observation suggested that early stages 
after birth are crucial for MSD pathology development, especially from the aspect 
of the neurological dysfunction, but that deeper investigation was needed.
Therefore, I isolated NSCs from neo-natal (P0) brain of wild-type and MSD 
mice, establishing a robust protocol that allows not only for the isolation, but also 
for the continuous in vitro expansion of NSCs, resembling and preserving all the 
morphological and molecular features of in vivo neuronal progenitors.
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As a first observation, MSD-NSCs display similar properties of their wild-type 
counterpart, suggesting that, with SUMF1 lack of function, progenitor cells maintain 
their radial glia identity, although they seem to have a progressive reduction of self- 
renew.
It has been shown that Hematopoietic Stem Cells (HSCs) isolated from MSD 
mice are characterized by an altered extracellular signaling of FGF and Wnt 
pathways (Buono et al. 2010). Self-renewal and differentiation of HSCs are 
balanced by the concerted activities of FGF, Wnt, and Notch pathways; Sulfl and 
Sulf2 are two non-lysosomal sulfatases, which are activated by SUMF1 post- 
translational modification and localize at the cell surface, where they mediate the 
remodeling of heparan sulfate proteoglycans (HSPGs). It has been demonstrated 
that Wnt controls tissue-specific cell fate decisions during embryogenesis, binding 
to the heparan sulfate moieties of HSPGs on the cell surface (Logan and Nusse 
2004; Bejsovec 2005). Sulf enzymes remove the sulfate from heparan sulfate, and 
releases Wnt from HSPGs. This released Wnt associates with Frizzled (Fz) and 
LRP5/6 receptors, resulting in inactivation of a multiprotein destruction complex, 
which in turn leads to the translocation of (B-catenin into the nucleus, where it 
activates several target genes (Hoppler and Kavanagh 2007). (3-catenin 
translocation in the cell nucleus has been shown to enhance self-renewal and 
maintain totipotency of ESCs and multipotency of HSCs (Reya et al. 2003; Suh et 
al. 2007). Thus, the impairment in the activities of Sulfl and Sulf2 in SUMF1 
deficient cells may alter the action of important extracellular signals by modifying 
the sulfation state of the heparan sulfates contained in HSPGs. In fact, crystal 
structure studies have demonstrated that binding of FGF1 and FGF2 to the FGF
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receptor is stabilized by sulfation of the heparan sulfates of the HSPGs (Pellegrini 
et al. 2000). It is also known that FGF signaling controls proliferation and 
subsequent lineage commitment of neural stem cells through a concerted action 
with p-catenin (Israsena et al. 2004).
Therefore, the self-renew impairment of MSD-NSCs observed in neurosphere 
assay may be ascribed to an alteration in the local concentration of important 
mitogenic factors bound to the HSPGs. Conversely, I did not observe any major 
block in the differentiation of MSD-NSCs, as glia and neurons expressed typical 
glia and neuronal markers, respectively, and they both did not show expression of 
the progenitor marker, as well as neurons outgrow neurites and were 
electrophysiologically active; nevertheless, more detailed and specific experiments 
are needed, in order to better quantify the extent of the differentiated cell 
population.
Isolated NSCs have the potency to generate the two main cell types of the 
CNS, glia and neurons, thus providing an in vitro model that can easily resemble all 
the main features of the developing brain. In fact, I did not observe defects in the 
differentiation of NSCs to the two main cell types of the brain, glia and neurons. 
However, the protocols I followed is one of the most accepted in order to visualize 
differentiation capacities in a grossly manner (Conti et al., 2005), but does not allow 
for a more specific analysis of diverse sub-populations actually present. In fact, 
NSCs can give rise also to oligodendrocytes, as well as different types of neurons; 
therefore, more detailed investigation on this aspect is needed, in order to evaluate 
whether the lack of SUMF1 can interfere with one or more of these cellular fate.
Furthermore, cellular differentiation is a progressive and committed process,
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in which a single defect becomes usually amplified and triggers a cascade of 
subsequent intracellular malfunctions, eventually leading to a severe 
neurodegeneration. The more the cells proceed in the developmental progression, 
the more restricted they become in their differentiation potential, losing their self­
renewal ability.
Altered autophagy is a hallmark of various LSDs, such as MSD and MPSIIIA 
(Settembre et al. 2008). As a degradative process, autophagy is responsible for 
constitutive protein turnover, a crucial function in neuronal cells and thus relevant 
to neurodegenerative diseases (Reggiori and Klionsky 2002). In agreement with in 
vivo data, we observed an increase of LC3-II levels in cellular extracts from 
differentiated MSD-NSCs, and accumulation of p62/SQSTM1 and poly- 
ubiquitinated proteins, both common components of protein aggregates in 
neurodegenerative diseases (Bjorkoy, Lamark, and Johansen 2006). We found 
that the accumulation of GAGs, poly-ubiquitinated proteins, and p62/SQSTM1 are 
likely to be associated with cell death. In fact, we observed that MSD-NSCs were 
more sensitive to apoptosis compared with wild-type cells, and in particular during 
the differentiation toward glial or neural cells. These findings correlate with the 
recent observation that defect in the recycling of dysfunctional mitochondria, 
through autophagy, could be involved in CNS neurodegeneration in MSD mouse 
model (de Pablo-Latorre et al. 2012).
Furthermore, I found a possible interesting correlation between impaired 
autophagy and aggresome formation and, although very preliminary, my data can 
suggest that, through this mechanism, the cell is protecting itself from toxic 
accumulation of proteins. Accumulation of misfolded proteins, indeed, is a
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prominent pathological feature common to many neurodegenerative diseases, 
including Parkinson's disease (PD), Alzheimer's disease (AD), HD, Amyotrophic 
Lateral Sclerosis (ALS) and many others; protein quality control is particularly 
important to neuronal homeostasis and normal function because neurons are post­
mitotic and unable to dilute cytotoxic misfolded proteins through cell division (Ross 
and Poirier 2004). Genetic mutations or environmental insults can induce many 
different proteins to misfold and aggregate, suggesting that a common pathological 
mechanism may link clinically distinct neurodegenerative diseases (Bucciantini et 
al. 2002; Kayed et al. 2003; Fandrich, Fletcher, and Dobson 2001; Glabe 2004). 
Interestingly, MSD and MPSIIIA cells present increased accumulation of 
overexpressed mutant forms of huntingtin and a-synuclein compared with wild-type 
counterparts, suggesting that protein aggregation may be activated in these 
diseases due to impaired autophagy (Settembre et al, 2008). In addition, recent 
findings demonstrate that certain regions of the brain of MPSIIIB mice show 
accumulation of hyperphosphorylated tau (Ptau) (Ohmi et al., 2009) and beta 
amyloid aggregations (Ohmi et al., 2011), both reminiscent of Alzheimer’s disease, 
suggesting that LSDs are likely to produce toxic protein aggregates, as well as 
other more known neurodegenerative diseases. Therefore, in order to clarify the 
aspect of protein aggregation in MSD pathology, a future challange will be to detect 
endogenous toxic proteins, such as huntingtin and a-synuclein, and follow their 
accumulation in post-mitotic cells.
In cultured cell, when the production of misfolded proteins exceeds the 
capacity of the ubiquitin-proteasome degradation pathway, misfolded proteins are 
actively transported to the aggresome. Aggresome formation is recognized as a
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cytoprotective response serving to sequester potentially toxic misfolded proteins 
and facilitate their clearance by autophagy (Fortun et al. 2003; Taylor et al. 2003; 
Iwata et al. 2005; Ravikumar, Duden, and Rubinsztein 2002). However, the deficit 
in autophagosome fusion with lysosome observed both in vivo and in vitro in MSD 
pathology can neutralize this cellular protective response, eventually worsening 
cellular viability.
TFEB-mediated activation of lysosomal exocytosis promotes the 
clearance of undegraded substrates
Establishing an in vitro system that was able to recapitulate all the main 
features of MSD prompted us to take advantage of the usefulness of this tool to 
explore possible therapeutic approaches, in the direction of reverting the pathologic 
phenotype. Towards this goal, we took advantage of the studies previously carried 
out in our laboratory on the bHLH transcription factor EB (TFEB) that was shown to 
coordinate lysosomal biogenesis, autophagy and also clearance in a neuronal 
model of HD (Sardiello et al. 2009; Settembre et al. 2011). Therefore we 
questioned whether TFEB-mediated increase of the lysosomal compartment could 
be exploited to induce the clearance of accumulated GAGs also in a neuronal 
cellular model of MSD.
Interestingly, TFEB overexpression resulted in a striking reduction of stored 
GAGs in MSD glial cells, as well as it induced recovery of normal intracellular 
morphology.
We also demonstrated that TFEB-mediated clearance of undegraded material
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is actually due to the activation of one of his target genes, the cation-channel 
MCOLN1, which is then responsible for the promotion of lysosomal exocytosis; in 
fact, MCOLN1 triggers the intracellular Ca2+ elevation, required to induce 
lysosomes to move to the proximity of the PM; once there, they expel their content 
in the extracellular space, thus mitigating the intracellular burden (Figure 31).
Finally, we confirmed the importance of our result, showing that TFEB 
delivery rescues tissue pathology in a mouse model of MSD; one month after 
TFEB systemic injection, we observed a significant reduction of GAG storage in 
crucial organs, such as liver and muscles. Interestingly, also macrophage 
infiltration and apoptosis were strongly reduced, thus indicating that TFEB action 
ameliorates not only primary defects, such as the accumulation of undegraded 
material, but also those secondary defects, such as inflammation and cell death, 
that are the main pathologic features of MSD. Future studies overexpressing TFEB 
in the brain of MSD mice will allow us to further confirm the benefits of modulating 
lysosomal function in order to reduce pathologic lysosomal accumulation in the 
CNS.
Our data indicate that lysosomal exocytosis can be exploited to promote 
cellular clearance in lysosomal storage diseases, suggesting an alternative 
strategy to treat disorders due to intracellular storage, such as LSDs and other 
more common neurodegenerative diseases. Several approaches, such as gene 
delivery, pharmacological induction of TFEB, and target gene activation, could be 
exploited to promote cellular clearance in target tissues. These strategies will have 
to be tested by long-term in vivo studies in animal models to verify the therapeutic 
potential of this discovery.
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As future investigation, it is particularly relevant that NSCs can be the perfect 
tool for drug screening, in order to find compounds able to induce cellular 
clearance, either in a TFEB-dependent or -independent way. As a second step, a 
very interesting goal will be to find genetic modulators of TFEB, whose expression 
can be modulated in order to achieve the clearance of undegraded substrates in 
LSDs. Toward this goal, I plan to use the very powerful and rapid genetic system of 
the fruit fly, Drosophila Melanogaster. Once generated all the fly models of LSDs, 
they can be used to validate in vivo drug targets that have been found to activate 
TFEB expression in a high-throughput cell screening. Furthermore, I can also 
conduct unbiased genetic screens on the whole fly genome to find genes that 
modify the phenotype of the diseases. This can enable us to uncover molecular 
pathways that are involved in the progression of LSDs. The screen may underlie 
interesting differences amongst them, but since several disorders share common 
features, it is very likely that the genetic screens will reveal common modifiers.
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Figure 31. Schematic representation of TFEB mechanism of action.
TFEB overexpression activates the network of lysosomal genes, includind 
MCOLN1, which in turn promotes lysosomal exocytosis, reducing the storage of 
undegraded substrates.
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MATERIALS AND METHODS
Isolation of NSCs and cell culture conditions
Neural tissue dissociation and positive selection of NSCs was achieved as 
described in results and following the manufacturer’s manual (Miltenyi Biotec, 
Cologne, Germany).
Isolated neurospheres were propagated in culture at clonal density on 
uncoated plates (Nunclon, Waltham, Massachusetts, USA) in ESGRO medium 
(Chemicon, Temecula, California, USA) containing 20 ng/mL EGF and 10 ng/mL 
FGF2 (Peprotech, Rocky Hill, New Jersey, USA) and with penicillin/streptomycin 
(NSC expansion medium). Over 3-5 days, cells formed aggregates that, after 
harvesting and sedimentation to remove debris, subsequently attached to fresh 
plastic and outgrew NS cells.
For derivation from established neurospheres, NSC monolayer cultures was 
achieved by dissociating to single cells using Accutase (Sigma, St. Louis, Missouri, 
USA) and plating at 104 cells/ml on poly-ornithine (Sigma, St. Louis, Missouri, 
USA)/laminin (Invitrogen, Carlsbad, California, USA) coated culture plates in NSC 
expansion medium. For passaging established NSC lines, it was routinely used 
accutase (Sigma), cells were collected in phosphate-buffered saline (PBS) and split 
1:3 to 1:5 every 2-3 days. The entire isolation protocol was carried out for three 
wild type and three Sumfl -/- mice.
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Flow cytometry analysis of nestin
NSCs were detached and dissociated with Accutase (Sigma, St. Louis, 
Missouri, USA), washed in PBS and triturated to a single cell suspension in PFN 
(15% PBS, 2% FCS, 0.1% sodium azide). Cells were distributed into 96-well U- 
bottomed microtiter plates (Nunc), fixed in 2% PFA (Sigma, St. Louis, Missouri, 
USA) for 20 minutes on ice, washed in PBS and incubated in PBS 0.5% saponin 
for 20 minutes on ice. After three washes in PBS 0.1% saponin, cells were 
incubated for 30 minutes on ice with a mouse anti-nestin primary antibody 
(Covance, Berkeley, California, USA) diluted 1:200 in PBS containing 0.1% 
saponin. After a further three washes, the cells were incubated for 30 minutes with 
a FITC-anti-mouse IgG diluted 1:200 in PBS 0.1% saponin. The cells were then 
washed in PBS 0.1% saponin and resuspended in PFN prior to Fluorescence- 
Activated Cell Sorting (FACS) analysis.
RT-PCR analysis
Total RNA was extracted from NSCs using RNeasy kit (Qiagen, Valencia, 
California, USA), and cDNA was generated using Superscript II (Invitrogen, 
Carlsbad, California, USA). Polymerase Chain Reaction (PCR) was performed for 
30 cycles for all markers except B-actin (25 cycles). The primers used were as 
follows: (3-actin (forward) 5’-GGCCCAGAGCAAGAGAGGTATCC-3’ and (reverse) 
5’-ACGCACGATTTCCCTCTCAGC-3’; oct4 (forward) 5’-
GGCGTT CT CTTT GG AAAG GT GTT C-3 ’ and (reverse) 5’-
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GTCGAACCACATCCTTCTCT-3’; nanog (forward) 5’-
AT G AAGT GCAAGCGGTGGCAG AAA-3’ and (reverse) 5’-
CCT GGTGG AGT CACAG AGT AGTT C-3’; pax6 (forward) 5’-
GCTTCATCCGAGTCTTCTCCGTTAG-3’ and (reverse) 5’-
CCATCTTTGCTTGGGAAATCCG-3’; BLBP (forward) 5’-
G GGT AAG ACCCG AGTT CCT C-3 ’ and (reverse) 5’-ATCACCACTTTGCCACCTTC-
3’; sox2 (forward) 5’-GGCGGCAACCAGAAGAACAG-3’ and (reverse) 5’-
GCTTGGCCTGCGTCG AT G AAC-3’; olig2 (forward) 5’-
GGCGGTGGCTTCAAGTCATC-3’ and (reverse) 5’-
TAGTTTCGCGCCAGCAGCAG-3’; mashl (forward) 5’-
CTCGT CCT CT CCGG AACT G ATG-3 ’ and (reverse) 5’-
CGACAGGACGCCGCGCTGAAAG-3’; dlx2 (forward) 5’-
AACCACGC ACC AT CT ACTCC-3’ and (reverse) 5’-CCGCTTTT CC AC AT CTT CTT- 
3’; nf-l (forward) 5’-GGATTCGCACAGCCTTCTC-3’ and (reverse) 5’- 
CCCTTCCTCTTCCAGCTTCT-3’.
Neurosphere assay
Cells were plated at 10 cells/pL in 24-well (0.5 mL/well) uncoated plates 
(Nunclon) in NSC expansion medium. The total number of spheres that formed in 
each well was counted after 7 days; the process was repeated similarly to generate 
secondary and tertiary neurospheres, after 15 and 21 days, respectively. Only 
colonies with a diameter > 100 pm were counted as spheres.
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Cell Differentiation
For glia differentiation, NSCs were plated onto 24-well gelatine coated plates 
at 105 cells/well in ESGRO medium supplemented with 1% fetal bovine serum 
(FBS) (Hyclone, Logan, Utah, USA) and without any supplemented growth factor 
(glia differentiation medium); rapid differentiation of NSC to GFAP positive glia 
occurs within 2 days.
For neural differentiation, NSCs were plated onto 24-well poly- 
ornithine/laminin coated plates in ESGRO medium (Chemicon, Temecula, 
California, USA) 0.5% B27 (GIBCO, San Diego, California, USA) and with 10 
ng/mL FGF2 (Peprotech, Rocky Hill, New Jersey, USA); a half volume of medium 
is replaced every 2-3 days to maintain conditioning of medium. After 7 days in 
these conditions, the media was switched to ESGRO medium (Chemicon, 
Temecula, California, USA) 0.5% B27 (GIBCO, San Diego, California, USA), 
without any growth factor. Half of the medium was exchanged every 2-3 days 
during the differentiation.
Immunofluorescence
To detect expression of intracellular markers, cells were plated on coated 
coverslips and fixed in PBS pH 7.4, 4% paraformaldehyde (PFA) (Sigma, St. Louis, 
Missouri, USA) for 20 minutes, quenched with 50 mM NH4CI for 15 minutes. Cells 
were incubated per 20 minutes in FBS (Hyclone, Logan, Utah, USA) with 0.2% 
Triton X-100 to block nonspecific binding and permeabilize membranes, and
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stained over-night with primary antibodies and for 2 hours with appropriate Alexa- 
594 and Alexa-488 conjugated secondary antibodies. Coverslips were mounted on 
glass slides in Vectashield with DAPI (Vector Laboratories, California, USA) to 
nuclear counterstaining and viewed on an epi-fluorescent or on a Zeiss LSM 510 
META confocal microscope (LSM510; Carl Zeiss, Thornwood, New York, USA) 
equipped with a Plan-Neofluar 63x immersion objective (Carl Zeiss, Inc.). Mice 
tissues were collected after PBS perfusion and fixed with 4% PFA (Sigma, St. 
Louis, Missouri, USA) for 12 h at 4°C and then subjected to a sucrose gradient 
(from 10 to 30%) and incubated over night in 30% sucrose at 4°C, before OCT 
embedding. Immunofluorescence analyses were performed on 10-mm-thick serial 
cryosections. The specimens were incubated for 1 hour with blocking solution 
(PBS, 0.2% Tween-20) and 10% goat normal serum (Sigma) before incubation 
over-night with the specific primary antibody. After washing, sections were 
incubated for 40 min with secondary antibody. Stained sections were mounted with 
Vectashield with DAPI (Vector Laboratories, California, USA). Primary antibodies 
were used at the following dilutions: mouse anti-Nestin (1:400) (Covance, Berkeley, 
California, USA); mouse anti-GFAP (1:300) (Sigma, St. Louis, Missouri, USA); 
mouse anti-Tuj1 (1:200) (Covance, Berkeley, California, USA); rabbit anti-LC3 
(1:200) (Novus Biological, Colorado, USA); mouse anti-CathD (1:500) (Sigma, St. 
Louis, Missouri, USA); rabbit anti-ubiquitin (1:100) (DakoCytomation, Carpinteria, 
California, USA); mouse anti-p62/SQSTM1 (1:200) (BD Biosciences, Franklin 
Lakes, New Jersey, USA); rabbit anti-HDAC6 (1:300) (Abeam, Cambridge, 
Massachusetts, USA); mouse anti-LAMP1 (1:500) (Sigma, St. Louis, Missouri, 
USA); rabbit anti-CD68 (1:250) (Serotech, Ontario, Canada) and mouse anti-flag
(1:200) (Sigma, St. Louis, Missouri, USA). Secondary antibodies were: goat anti­
rabbit (1:3000) and donkey anti-mouse (1:5000) conjugated to Alexa Fluor 488 or 
594 (Molecular Probes, Eugene, Oregon, USA).
Immunoblotting
Cells were lysed in cold lysis buffer (20 mM Tris-HCI, pH 7.4,150 mM NaCI, 
1% TritonX-100) in the presence of protease inhibitors (Roche Diagnostics, 
Indianapolis, Indiana, USA) for 30 minutes on ice. Proteins were quantified by the 
Bradford method. 10-20 ug of protein samples were separated on SDS-PAGE 
acrylamide gel and transferred onto nitrocellulose membrane (Amersham 
Pharmacia Biotech, Uppsala, Sweden). Primary and HRP-conjugated secondary 
antibodies were diluted in 5% milk TBS-T. Bands were visualized using the ECL 
detection reagent (Pierce, Rockford, Illinois, USA) and normalized against actin. 
Antibodies were used as follows: mouse anti-GFAP (1:300) (Sigma, St. Louis, 
Missouri, USA); mouse anti-Tuj1 (1:200) (Covance, Berkeley, California, USA); 
rabbit anti-LC3 (1:200) (Novus Biological, Colorado, USA); rabbit anti-ubiquitin 
(1:100) (DakoCytomation, Carpinteria, California, USA); mouse anti-p62/SQSTM 
(1:200) (BD Biosciences, Franklin Lakes, New Jersey, USA); rabbit anti-HDAC6 
(1:300) (Abeam, Cambridge, Massachusetts, USA); mouse anti-vimentin (1:300) 
(Santa Cruz Biotechnology, Santa Cruz, California, USA); and rabbit anti-Bactin 
(1:10000) (Sigma, St. Louis, Missouri, USA). HRP-conjugated secondary 
antibodies were: rabbit anti-mouse (1:3000) and mouse anti-rabbit (1:3000) 
(Amersham, Uppsala, Sweden).
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Neurite Outgrowth Assay
Neurite assay was performed following the manufacturer’s manual 
(Millipore). Differentiating neurons were placed in Millicell 12-well inserts containing 
neural differentiation medium at a concentration of 100,000 cells/100 pL (1 x 106 
cells/mL). Plates were incubated at 37°C for 3 and 7 days. Following the neurite 
extension period, each insert was removed from the culture well, washed with PBS 
and fixed in cold methanol for 20 minutes at room temperature. Then the insert was 
stained for 15-30 minutes with Neurite Stain Solution, washed with PBS and then 
cell bodies were gently swabed from top of insert. Neurite Stain Extraction Buffer 
was added to the top of each swabbed inserts and incubate for 5 minutes at room 
temperature. Inserts were spinned and then read at an absorbance of 590 nm.
Electrophysiology and patch clamp recording
Recordings were made from NSC-derived neurons, differentiated between 
passages 20-25. Seals between electrodes and cells were established in a bath 
solution consisting of (in mmoles/I): 138 NaCI, 2 CaCh, 5.4 KCI, 1 MgCk, 10 
glucose and 10 HEPES, pH 7.4 with NaOH; the pipette (intracellular) solution 
contained (in millimolar): 140 KCI, 2 MgCI2, 10 EGTA, 10 HEPES, 5 Mg-ATP, pH 
7.3-7.4 with KOH. The pCLAMP software (version 10.0.2) was used for data 
acquisition and analysis.
Ionic currents were recorded under voltage-clamp conditions using the patch- 
clamp whole-cell configuration at room temperature (20-24°C) with an Axopatch
121
200B patch-clamp amplifier (Axon Instruments, Burlingame, California, USA). For 
Ionic currents recording the following protocol was applied: from an holding 
potential of -90 mV, a short (50 ms) pulse to -100 mV followed by a series of 
progressively increasing depolarizations (from -100 mV to +40 mV) of 50 ms 
duration, before a final 50 ms step to -100 mV was applied. Data were filtered at 5 
kHz and sampled at 50 kHz. Capacitance currents were compensated by analog 
circuitry and subtracted on-line by using a p/-4 protocol from a subtracting holding 
potential of -100 mV.
Electron Microscopy (EM) and immuno-gold analysis
Cells were washed with PBS and fixed at room temperature in 0.05% 
glutaraldehyde (Polysciences, Warrington, Pennsylvania, USA) dissolved in 0.2 M 
Hepes buffer (pH 7.4) for 30 minutes at room temperature. Then, cells were 
scraped off the dish, pelletted by centrifugation and postfixed for 2 hours in 1% 
Os04 (Polysciences, Warrington, Pennsylvania, USA) in the same buffer. After en- 
bloc staining with 1% uranyl acetate for 1 hour and ethanol dehydration, cells were 
embedded in Epon-812 (Fluka, Ronkonkoma, New York, USA) and polymerized at 
60°C for 72 hours. Thin sections were cut at the Leica EM UC6 and counterstained 
with uranyl acetate and lead citrate. Images were acquired from thin sections using 
a Philips Tecnai-12 electron microscope equipped with an ULTRA VIEW CCD 
digital camera (Philips, Eindhoven, Netherlands).
For immuno-gold HeLa and CF7 cells were fixed with a mixture of 4% 
paraformaldehyde and 0.05% glutaraldehyde, labeled with a monoclonal antibody
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against LAMP1 according the gold-enhance protocol, embedded in Epon-812, and 
cut as described previously (Polishchuk et al. 2003). EM images were acquired 
from thin sections using a Philips Tecnai-12 electron microscope equipped with an 
ULTRA VIEW CCD digital camera (Philips, Eindhoven, Netherlands). Quantification 
of vacuolization was performed using the AnalySIS software (Soft Imaging Systems 
GmbH, Muenster, Germany). Evaluation of lysosome distance from the PM was 
done in EM images using the iTEM software (Soft Imaging Systems GmbH). 
Selection of cells for quantification was based on their suitability for stereologic 
analysis, i.e., only cells sectioned through their central region (detected on the 
basis of the presence of Golgi membranes) were analyzed.
Alcian Blue staining
Undifferentiated cells, glia and neurons were stained with 1% Alcian blue 
(Sigma, St. Louis, Missouri, USA) in hydrochloric acid. The counterstaining was 
performed for 2 minutes with Nuclear-Fast red (Sigma, St. Louis, Missouri, USA).
After the perfusion of the animals with PBS, the tissues were collected and 
fixed in methacarn solution (30% chloroform, 60% methanol and 10% acetic acid) 
for 24 hours at 4°C. The next day, the tissues were embedded in paraffin (Sigma, 
St. Louis, Missouri, USA) after their dehydration with a 70-100% ethanol gradient. 
Finally, the tissues were sectioned into 7 mm thick serial sections on a microtome. 
Sections of paraffin-embedded tissues were stained with 1% Alcian blue (Sigma, 
St. Louis, Missouri, USA) and counterstained with Nuclear-Fast red (Sigma, St. 
Louis, Missouri, USA).
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GAG quantitative assay
The protein extracts were assayed with the dimethylmethylene blue-based 
spectrophotometry of glycosaminoglycans (de Jong et al. 1989). The samples were 
read at 520 nm and the GAG concentrations were determined using the heparan 
sulfate standard curve (Sigma, St. Louis, Missouri, USA). Tissue GAG amount was 
expressed as yg GAG/pg protein.
GAG pulse-and-chase analysis
Cells were grown in differentiation medium in presence of 7pCi/ml 3H- 
glucosamine hydrochloride (37.75 Ci/mmol, Perkin Elmer, Massachusetts, USA) for 
24 hours, washed extensively with PBS and then chased. At the end of the chasing 
time, cells were harvested, homogenized and subject to chromatography on 
Sephadex G-25 columns (GE Healthcare, Sweden) to eliminate unincorporated 3H- 
glucosamine hydrochloride. The amounts of incorporated or secreted radioactivity 
was measured by liquid scintillation in a Beckman LS6500 counter (Beckman 
Instruments, Fullerton, CA, USA).
TUN EL assay
Cells apoptosis was detected by TUN EL assay following the manufacturer’s 
manual (Roche, Basle, Switzerland). TUNEL-positive cells were quantitated 
microscopically.
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TUNEL assay on tissue was performed by using the ApopTag Peroxidase In 
Situ Apoptosis Detection kit following the manufacturer’s manual (Oncor, 
Gaithersburg, Maryland, USA).
Transfection and nucleofection
NSCs, HeLa cells and human fibroblasts were transfected using PolyFect 
Transfection Reagent (QIAGEN, Hilden, Germany), according to the 
manufacturer’s protocols. HeLa CF7 stable cell lines was previously described 
(Sardiello et al. 2009). The HeLashMC0LN1 cell line was generated by infection with 
MCOLN1 lentiviral shRNA. NSCs were transfected by using nucleofection (Amaxa, 
Lonza, Walkersville, Maryland, USA).
Staining for Surface LAMP1
Cells were grown on glass coverslips, incubated with anti-rat LAMP1 (1DB4; 
Santa Cruz Biotechnology, Santa Cruz, CA) diluted in PBS 1% BSA at 4°C for 30 
minutes. Cells were washed in PBS and fixed in 4% PFA (Sigma, St. Louis, 
Missouri, USA) for 15 minutes at 4°C, washed in PBS, and incubated with Alexa- 
594 conjugated anti-rat secondary antibodies (Molecular Probes, Eugene, Oregon, 
USA) for 30 minutes at room temperature. Coverslips were mounted on glass 
slides with Vectashield (Vector Laboratories, California, USA). Finally, cells were 
analyzed on a confocal microscope (LSM510; Carl Zeiss, Thornwood, New York, 
USA) equipped with Plan-Neofluar 63x immersion objective.
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Flow Cytometry analysis of surface LAMP1
Confluent cells transfected with TFEB-GFP constructs were trypsinized and 
washed twice with PBS before incubation with PBS for 5 min at 37°C. 109 cells for 
each assay were centrifuged and resuspended in PBS 1% BSA with anti-rat 
LAMP1-1DB4 at 4°C for 30 minutes. Cells were washed in PBS and fixed in 2% 
paraformaldehyde for 15 minutes. Cells were further incubated with Alexa-594 
conjugated anti-rat secondary antibodies (Molecular Probes, Eugene, Oregon, 
USA) for 30 minutes at room temperature. Finally, cells were washed, resuspended 
in 0.5 ml PBS, and analyzed on a FACS Aria Flow Cytometer (Becton Dickinson & 
Co., Mountain View, California, USA). Forward angle scatter, right angle scatter, 
and fluorescence intensity were recorded from 50,000 cells whose forward angle 
scatter fell above a threshold used to distinguish intact GFP-positive cells from both 
non-transfected or damaged cells.
Enzymatic Activities
Enzyme activities were measured with the appropriate fluorimetric or 
colorimetric substrates. Specifically, acid phosphatase and B-hexosaminidase 
activities were measured using the Acid-Phosphatase and 6-N- 
Acerylglucosaminidase assay kit (Sigma, St. Louis, Missouri, USA), repectively. 6- 
galactosidase was measured by a colorimetric assay using 4-methylumbelliferyl-(B- 
D-galactopyranoside as substrate in 0,5M NaAc buffer, pH 5.0. Lactate de­
hydrogenase (LDH) activity was measured using the LDH-Cytotoxicity Assay Kit
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(Abeam, Cambridge, Massachusetts, USA). To measure enzyme activities in the 
medium, cells were incubated in medium containing 1% BSA (w/v). Protein 
concentrations were determined using the BCA-assay (Pierce, Rockford, Illinois, 
USA).
Calcium Measurements by Confocal Imaging
TFEB-GFP-transfected cells were treated with FuraRed for 30 minutes in a 
Ca2+ imagin buffer and analyzed according to the manufacturer’s instructions 
(Invitrogen).
Flow Cytometric Calcium Flux Assay
Cell preparation and loading was performed following a protocol already 
described (Schepers et al. 2009) with some modifications. Briefly, cells were 
loaded with Fluo-3AM and FuraRed-AM (Molecular Probes, Eugene, Oregon, USA) 
for 30 minutes at 37°C. After a wash in PBS without Ca2+, the cells were 
resuspended in the appropriate buffer in accordance to the different conditions and 
kept at RT until analysis. Ca2+-entry is prevented by the use of a PBS buffer 
without Ca2+ and containing 1 mM sodium pyruvate, 25 mM HEPES and 5 mM 
EGTA, the latter to exclude remaining traces of Ca2+ contamination. In these 
Fluo3/FuraRed-loaded cells the release of Ca2+ from the intracellular stores can 
be studied. Samples were analysed using the FACS Aria Flow Cytometer (Becton
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Dickinson & Co., Mountain View, California, USA). Following preparation, samples 
were aspirated during 30 seconds to determine the baseline fluorescence of the 
Fluo3 and FuraRed. Then, after the addition of ionomycin (5 pM), the acquisition 
was resumed with changes in Ca2+ concentration being recorded over a 150 
seconds time period. Changes in the fluorescence (FL) intensity of the Fluo3 and 
FuraRed were measured on the FL-1 and FL-2 channels. The ratio of baseline 
Fluo3/FuraRed was plotted. Data are expressed as means ± standard deviation 
(SD). A p-value of less than 0.05 was considered significant.
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